000005944012/312022Q1FALSE00000594402022-01-012022-03-3100000594402022-05-06xbrli:shares00000594402022-03-31iso4217:USD00000594402021-12-31iso4217:USDxbrli:shares0000059440vgr:TobaccoSegmentMember2022-01-012022-03-310000059440vgr:TobaccoSegmentMember2021-01-012021-03-310000059440vgr:RealEstateSegmentMember2022-01-012022-03-310000059440vgr:RealEstateSegmentMember2021-01-012021-03-3100000594402021-01-012021-03-310000059440us-gaap:CommonStockMember2021-12-310000059440us-gaap:AdditionalPaidInCapitalMember2021-12-310000059440us-gaap:RetainedEarningsMember2021-12-310000059440us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000059440us-gaap:RetainedEarningsMember2022-01-012022-03-310000059440us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000059440us-gaap:CommonStockMember2022-01-012022-03-310000059440us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000059440us-gaap:CommonStockMember2022-03-310000059440us-gaap:AdditionalPaidInCapitalMember2022-03-310000059440us-gaap:RetainedEarningsMember2022-03-310000059440us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000059440us-gaap:CommonStockMember2020-12-310000059440us-gaap:AdditionalPaidInCapitalMember2020-12-310000059440us-gaap:RetainedEarningsMember2020-12-310000059440us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-3100000594402020-12-310000059440us-gaap:RetainedEarningsMember2021-01-012021-03-310000059440us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310000059440us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310000059440us-gaap:CommonStockMember2021-01-012021-03-310000059440us-gaap:CommonStockMember2021-03-310000059440us-gaap:AdditionalPaidInCapitalMember2021-03-310000059440us-gaap:RetainedEarningsMember2021-03-310000059440us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-3100000594402021-03-310000059440vgr:NewValleyLlcMember2021-01-012021-03-310000059440us-gaap:RestrictedStockMember2022-01-012022-03-310000059440us-gaap:RestrictedStockMember2021-01-012021-03-310000059440vgr:DouglasEllimanRealtyLlcMembervgr:TransitionServicesAgreementMember2022-01-012022-03-310000059440vgr:AviationAgreementsMembervgr:DouglasEllimanRealtyLlcMember2022-01-012022-03-310000059440vgr:DouglasEllimanRealtyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-01-012022-03-310000059440vgr:DouglasEllimanRealtyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-01-012021-03-310000059440vgr:RealEstateSegmentMembervgr:SalesOnFacilitiesMember2022-01-012022-03-310000059440vgr:RealEstateSegmentMembervgr:SalesOnFacilitiesMember2021-01-012021-03-310000059440vgr:RealEstateSegmentMembervgr:RevenuesFromInvestmentsInRealEstateMember2022-01-012022-03-310000059440vgr:RealEstateSegmentMembervgr:RevenuesFromInvestmentsInRealEstateMember2021-01-012021-03-310000059440vgr:RealEstateSegmentMember2022-01-012022-03-310000059440vgr:RealEstateSegmentMember2021-01-012021-03-310000059440srt:MinimumMember2022-03-310000059440srt:MaximumMember2022-03-310000059440vgr:DouglasEllimanLLCMemberus-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember2022-01-012022-03-310000059440vgr:DouglasEllimanLLCMemberus-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleSpinoffMember2021-01-012021-03-310000059440vgr:LeafTobaccoMember2022-03-310000059440vgr:OtherRawMaterialsMember2022-03-310000059440vgr:WorkinProcessMember2022-03-310000059440vgr:FinishedGoodsMember2022-03-310000059440vgr:LeafTobaccoMember2021-12-310000059440vgr:OtherRawMaterialsMember2021-12-310000059440vgr:WorkinProcessMember2021-12-310000059440vgr:FinishedGoodsMember2021-12-310000059440us-gaap:InventoriesMember2022-03-310000059440us-gaap:InventoriesMember2021-12-310000059440us-gaap:InventoriesMembervgr:LiggettMember2022-01-012022-03-310000059440vgr:MarketableEquitySecuritiesMember2022-03-310000059440vgr:MarketableEquitySecuritiesMember2021-12-310000059440us-gaap:FixedIncomeFundsMember2022-03-310000059440us-gaap:FixedIncomeFundsMember2021-12-310000059440vgr:MarketableDebtSecuritiesMember2022-03-310000059440us-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-03-310000059440us-gaap:CorporateDebtSecuritiesMember2022-03-310000059440us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-03-310000059440us-gaap:CommercialPaperMember2022-03-310000059440us-gaap:ForeignGovernmentDebtSecuritiesMember2022-03-310000059440vgr:MarketableDebtSecuritiesMember2021-12-310000059440vgr:HedgeFundsEquityMethodInvestmentMember2022-03-310000059440vgr:HedgeFundsEquityMethodInvestmentMember2021-12-31xbrli:pure0000059440vgr:HedgeFundsEquityMethodInvestmentMember2022-01-012022-03-310000059440vgr:HedgeFundsEquityMethodInvestmentMember2021-01-012021-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMembersrt:MinimumMember2022-03-310000059440srt:AffiliatedEntityMembersrt:MaximumMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMember2022-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMember2022-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMember2021-12-310000059440srt:AffiliatedEntityMembervgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMembersrt:MinimumMember2022-03-310000059440srt:AffiliatedEntityMembersrt:MaximumMembervgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMember2022-03-310000059440srt:AffiliatedEntityMembervgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMember2022-03-310000059440srt:AffiliatedEntityMembervgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMember2021-12-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMember2022-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMember2021-12-310000059440srt:AffiliatedEntityMemberus-gaap:NonUsMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:ApartmentBuildingMember2022-03-310000059440srt:AffiliatedEntityMembervgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:ApartmentBuildingMember2022-03-310000059440srt:AffiliatedEntityMembervgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:ApartmentBuildingMember2021-12-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:ApartmentBuildingMember2022-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:ApartmentBuildingMember2021-12-310000059440srt:HotelMembersrt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMembersrt:MinimumMember2022-03-310000059440srt:HotelMembersrt:AffiliatedEntityMembersrt:MaximumMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMember2022-03-310000059440srt:HotelMembersrt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMember2022-03-310000059440srt:HotelMembersrt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMember2021-12-310000059440srt:HotelMembersrt:AffiliatedEntityMemberus-gaap:NonUsMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-03-310000059440srt:HotelMembersrt:AffiliatedEntityMemberus-gaap:NonUsMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-12-310000059440srt:HotelMembersrt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-03-310000059440srt:HotelMembersrt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-12-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:RetailSiteMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMember2022-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:RetailSiteMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMember2021-12-310000059440srt:AffiliatedEntityMembervgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:RetailSiteMember2022-03-310000059440srt:AffiliatedEntityMembervgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:RetailSiteMember2021-12-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:RetailSiteMember2022-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:RetailSiteMember2021-12-310000059440srt:AffiliatedEntityMembersrt:OtherPropertyMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MinimumMember2022-03-310000059440srt:AffiliatedEntityMembersrt:MaximumMembersrt:OtherPropertyMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-03-310000059440srt:AffiliatedEntityMembersrt:OtherPropertyMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-03-310000059440srt:AffiliatedEntityMembersrt:OtherPropertyMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-12-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-12-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMember2022-01-012022-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMember2021-01-012021-03-310000059440srt:AffiliatedEntityMembervgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMember2022-01-012022-03-310000059440srt:AffiliatedEntityMembervgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMember2021-01-012021-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMember2022-01-012022-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:MultifamilyMember2021-01-012021-03-310000059440srt:HotelMembersrt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMember2022-01-012022-03-310000059440srt:HotelMembersrt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMember2021-01-012021-03-310000059440srt:HotelMembersrt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-01-012022-03-310000059440srt:HotelMembersrt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-01-012021-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:RetailSiteMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMember2022-01-012022-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:RetailSiteMembervgr:NewYorkCityStandardMetropolitanStatisticalAreaMember2021-01-012021-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:RetailSiteMember2022-01-012022-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:RetailSiteMember2021-01-012021-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-01-012022-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-01-012021-03-310000059440srt:AffiliatedEntityMembervgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:ApartmentBuildingMember2022-01-012022-03-310000059440srt:AffiliatedEntityMembervgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:ApartmentBuildingMember2021-01-012021-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:ApartmentBuildingMember2022-01-012022-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:ApartmentBuildingMember2021-01-012021-03-310000059440srt:AffiliatedEntityMembervgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:RetailSiteMember2022-01-012022-03-310000059440srt:AffiliatedEntityMembervgr:AllOtherU.S.AreasExcludingNewYorkCityStandardMetropolitanStatisticalAreaMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembersrt:RetailSiteMember2021-01-012021-03-310000059440srt:AffiliatedEntityMembersrt:OtherPropertyMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-01-012022-03-310000059440srt:AffiliatedEntityMembersrt:OtherPropertyMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-01-012021-03-310000059440srt:HotelMembersrt:AffiliatedEntityMemberus-gaap:NonUsMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-01-012022-03-310000059440srt:HotelMembersrt:AffiliatedEntityMemberus-gaap:NonUsMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-01-012021-03-31vgr:venture0000059440srt:AffiliatedEntityMembersrt:OtherPropertyMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:UnconsolidatedPropertiesMember2022-01-012022-03-310000059440srt:AffiliatedEntityMembersrt:OtherPropertyMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:UnconsolidatedPropertiesMember2021-01-012021-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembervgr:EscenaMember2022-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembervgr:EscenaMember2021-12-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembervgr:EscenaMember2022-01-012022-03-310000059440srt:AffiliatedEntityMembervgr:NewValleyLlcMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMembervgr:EscenaMember2021-01-012021-03-310000059440srt:AffiliatedEntityMemberus-gaap:SubsequentEventMembervgr:NewValleyLlcMembervgr:EscenaMember2022-04-012022-04-300000059440us-gaap:SeniorNotesMembervgr:A575SeniorSecuredNotesDue2029Member2022-03-310000059440us-gaap:SeniorNotesMembervgr:A575SeniorSecuredNotesDue2029Member2021-12-310000059440vgr:A10.5SeniorNotesdue2026Memberus-gaap:ConvertibleDebtMember2022-03-310000059440vgr:A10.5SeniorNotesdue2026Memberus-gaap:ConvertibleDebtMember2021-12-310000059440us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembervgr:LiggettMember2022-03-310000059440us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMembervgr:LiggettMember2021-12-310000059440us-gaap:SecuredDebtMembervgr:LiggettMember2022-03-310000059440us-gaap:SecuredDebtMembervgr:LiggettMember2021-12-310000059440us-gaap:NotesPayableOtherPayablesMember2022-03-310000059440us-gaap:NotesPayableOtherPayablesMember2021-12-310000059440us-gaap:SeniorNotesMembervgr:A575SeniorSecuredNotesDue2029Member2021-01-280000059440vgr:A6.125SeniorSecuredNotesdue2025Memberus-gaap:SeniorNotesMember2021-02-010000059440vgr:A6.125SeniorSecuredNotesdue2025Memberus-gaap:SeniorNotesMember2021-01-012021-03-310000059440us-gaap:SeniorNotesMembervgr:A10.5SeniorNotesdue2026Member2022-03-310000059440us-gaap:LineOfCreditMembervgr:LiggettMember2022-03-310000059440vgr:A6.125SeniorSecuredNotesdue2025Memberus-gaap:SeniorNotesMember2022-01-012022-03-310000059440us-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-03-310000059440us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2022-03-310000059440us-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000059440us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMember2021-12-310000059440us-gaap:OtherDebtSecuritiesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-03-310000059440us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:OtherDebtSecuritiesMember2022-03-310000059440us-gaap:OtherDebtSecuritiesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000059440us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:OtherDebtSecuritiesMember2021-12-310000059440us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-03-310000059440us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-03-310000059440us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000059440us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000059440vgr:LiggettMember2022-01-012022-03-310000059440vgr:LiggettMember2021-01-012021-03-310000059440us-gaap:SuretyBondMembervgr:LiggettMember2022-03-310000059440stpr:FLvgr:LiggettMembervgr:EngleProgenyCasesMember2009-06-300000059440vgr:IndividualActionsCasesMembervgr:LiggettMember2022-03-31vgr:case0000059440vgr:IndividualActionsCasesMemberstpr:FLvgr:LiggettMember2022-03-310000059440vgr:IndividualActionsCasesMemberstpr:ILvgr:LiggettMember2022-03-310000059440vgr:IndividualActionsCasesMemberstpr:NVvgr:LiggettMember2022-03-310000059440vgr:IndividualActionsCasesMemberstpr:NMvgr:LiggettMember2022-03-310000059440vgr:IndividualActionsCasesMemberstpr:HIvgr:LiggettMember2022-03-310000059440vgr:IndividualActionsCasesMembervgr:LiggettMemberstpr:LA2022-03-310000059440vgr:IndividualActionsCasesMemberstpr:MAvgr:LiggettMember2022-03-310000059440vgr:IndividualActionsCasesMemberstpr:SCvgr:LiggettMember2022-03-31vgr:loan0000059440vgr:EngleProgenyCasesMember1996-11-211996-11-210000059440vgr:LiggettMembervgr:EngleProgenyCasesMember1996-11-211996-11-210000059440vgr:LiggettMembervgr:EngleProgenyCasesMember2022-03-310000059440vgr:LiggettMembervgr:EngleProgenyCasesMember2013-10-012013-10-310000059440vgr:LiggettMembervgr:EngleProgenyCasesMember2015-02-012015-02-280000059440vgr:LiggettMembervgr:EngleProgenyCasesMember2013-10-310000059440vgr:EngleProgenyCasesSettledSeparateMembervgr:LiggettMember2022-01-012022-03-31vgr:agreementvgr:plaintiff0000059440vgr:LiggettMembervgr:EngleProgenyCasesMember2022-01-012022-03-310000059440vgr:EngleProgenyCasesCurrentSettlementsMembervgr:LiggettMember2022-01-012022-03-310000059440vgr:LiggettAndVectorTobaccoMembervgr:EngleProgenyCasesMember2022-03-310000059440vgr:LukacsCampbellDouglasClayTulloWardRizzutoLambertBuchananAndSantoroMembervgr:LiggettMember2022-01-012022-03-310000059440vgr:EngleProgenyCasesCowartTuminForbingAndJonesMembervgr:LiggettMember2022-03-310000059440vgr:EngleProgenyCasesBaronCamachoClarkCuppFeldGeistLaneNicholsonMendezAndTullyMembervgr:LiggettMember2022-03-310000059440vgr:IndividualActionsCasesMemberstpr:MDvgr:LiggettMember2017-06-300000059440vgr:ClassActionsMembervgr:LiggettAndOtherCigaretteManufacturersMember2022-03-310000059440vgr:ParsonsVAcSIncMember2000-12-31vgr:defendant0000059440vgr:LiggettMembervgr:CrowCreekSiouxTribev.AmericanTobaccoCompanyMember2022-03-310000059440vgr:LiggettMember1996-03-011998-03-31vgr:state0000059440vgr:HealthCareCostRecoveryActionsMember1998-11-011998-11-300000059440vgr:HealthCareCostRecoveryActionsMember1996-03-011998-03-31vgr:sponsorship0000059440vgr:LiggettMembervgr:HealthCareCostRecoveryActionsMember2022-03-310000059440vgr:HealthCareCostRecoveryActionsMembervgr:VectorTobaccoMember2022-03-310000059440vgr:LiggettAndVectorTobaccoMember2021-01-012021-12-310000059440vgr:LiggettAndVectorTobaccoMembervgr:HealthCareCostRecoveryActionsMember2020-12-302020-12-300000059440vgr:LiggettAndVectorTobaccoMembervgr:HealthCareCostRecoveryActionsMember2021-12-310000059440vgr:HealthCareCostRecoveryActions2003NPMAdjustmentMember2010-06-012010-06-300000059440vgr:HealthCareCostRecoveryActions2003NPMAdjustmentMember2022-03-310000059440vgr:HealthCareCostRecoveryActions2003NPMAdjustmentMember2022-01-012022-03-310000059440vgr:HealthCareCostRecoveryActionsNPMAdjustmentMemberus-gaap:CostOfSalesMember2022-01-012022-03-310000059440vgr:HealthCareCostRecoveryActionsNPMAdjustmentMemberus-gaap:CostOfSalesMember2021-01-012021-03-310000059440vgr:LiggettAndVectorTobaccoMembervgr:HealthCareCostRecoveryActions20042010NPMAdjustmentMember2022-03-310000059440vgr:HealthCareCostRecoveryActions20112015NPMAdjustmentMembervgr:LiggettMember2022-03-310000059440vgr:LiggettMembervgr:HealthCareCostRecoveryActionsMember1996-03-011998-03-310000059440vgr:LiggettMembervgr:HealthCareCostRecoveryActionsMemberstpr:MN2003-01-012003-12-310000059440stpr:FLvgr:LiggettMembervgr:HealthCareCostRecoveryActionsMember2011-01-012011-03-310000059440stpr:MSvgr:LiggettMembervgr:HealthCareCostRecoveryActionsMember2016-01-012016-01-310000059440stpr:MSvgr:LiggettMembervgr:HealthCareCostRecoveryActionsMember2021-04-012021-04-300000059440stpr:MSvgr:LiggettMembervgr:HealthCareCostRecoveryActionsMember2021-08-012021-08-310000059440us-gaap:SettledLitigationMember2021-12-310000059440us-gaap:PendingLitigationMember2021-12-310000059440us-gaap:SettledLitigationMember2022-01-012022-03-310000059440us-gaap:PendingLitigationMember2022-01-012022-03-310000059440us-gaap:SettledLitigationMember2022-03-310000059440us-gaap:PendingLitigationMember2022-03-310000059440us-gaap:SettledLitigationMember2020-12-310000059440us-gaap:PendingLitigationMember2020-12-310000059440us-gaap:SettledLitigationMember2021-01-012021-03-310000059440us-gaap:PendingLitigationMember2021-01-012021-03-310000059440us-gaap:SettledLitigationMember2021-03-310000059440us-gaap:PendingLitigationMember2021-03-310000059440vgr:AltriaClientServicesMember2022-01-012022-03-31vgr:indemnity_demand0000059440us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000059440us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2022-03-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2022-03-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2022-03-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2022-03-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2022-03-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2022-03-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2022-03-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2022-03-310000059440vgr:MarketableEquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000059440us-gaap:FairValueInputsLevel1Membervgr:MarketableEquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000059440vgr:MarketableEquitySecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000059440us-gaap:FairValueInputsLevel3Membervgr:MarketableEquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeFundsMember2022-03-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeFundsMember2022-03-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeFundsMember2022-03-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeFundsMember2022-03-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2022-03-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2022-03-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2022-03-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2022-03-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-03-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-03-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-03-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-03-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2022-03-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2022-03-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2022-03-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2022-03-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-03-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-03-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-03-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2022-03-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2022-03-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2022-03-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2022-03-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2022-03-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2022-03-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2022-03-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2022-03-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2022-03-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeSecuritiesMember2022-03-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeSecuritiesMember2022-03-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeSecuritiesMember2022-03-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeSecuritiesMember2022-03-310000059440us-gaap:FairValueMeasurementsRecurringMember2022-03-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000059440us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000059440us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2021-12-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2021-12-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2021-12-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2021-12-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2021-12-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2021-12-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2021-12-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2021-12-310000059440vgr:MarketableEquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000059440us-gaap:FairValueInputsLevel1Membervgr:MarketableEquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000059440vgr:MarketableEquitySecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000059440us-gaap:FairValueInputsLevel3Membervgr:MarketableEquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeFundsMember2021-12-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeFundsMember2021-12-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeFundsMember2021-12-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeFundsMember2021-12-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2021-12-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2021-12-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2021-12-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2021-12-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2021-12-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2021-12-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2021-12-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember2021-12-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2021-12-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2021-12-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2021-12-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2021-12-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2021-12-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2021-12-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2021-12-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2021-12-310000059440us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeSecuritiesMember2021-12-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeSecuritiesMember2021-12-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeSecuritiesMember2021-12-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FixedIncomeSecuritiesMember2021-12-310000059440us-gaap:FairValueMeasurementsRecurringMember2021-12-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000059440us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000059440us-gaap:FairValueInputsLevel3Membervgr:MonteCarloSimulationModelMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2022-03-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembervgr:MonteCarloSimulationModelMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000059440us-gaap:FairValueInputsLevel3Membervgr:MonteCarloSimulationModelMemberus-gaap:FairValueMeasurementsRecurringMembervgr:MeasurementInputLeverageAdjustedEquityandVolatilityofPeerFirmsMember2022-03-310000059440us-gaap:FairValueInputsLevel3Membervgr:MonteCarloSimulationModelMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MeasurementInputDiscountForLackOfMarketabilityMember2021-12-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputRiskFreeInterestRateMembervgr:MonteCarloSimulationModelMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000059440us-gaap:FairValueInputsLevel3Membervgr:MonteCarloSimulationModelMemberus-gaap:FairValueMeasurementsRecurringMembervgr:MeasurementInputLeverageAdjustedEquityandVolatilityofPeerFirmsMember2021-12-3100000594402021-01-012021-12-310000059440us-gaap:FairValueMeasurementsNonrecurringMember2021-12-310000059440us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsNonrecurringMember2021-12-310000059440us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310000059440us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2021-12-310000059440us-gaap:OperatingSegmentsMembervgr:TobaccoSegmentMember2022-01-012022-03-310000059440vgr:RealEstateSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000059440vgr:CorporateAndReconcilingItemsMember2022-01-012022-03-310000059440us-gaap:OperatingSegmentsMembervgr:TobaccoSegmentMember2021-01-012021-03-310000059440vgr:RealEstateSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000059440vgr:CorporateAndReconcilingItemsMember2021-01-012021-03-310000059440us-gaap:OperatingSegmentsMembervgr:TobaccoSegmentMembervgr:HealthCareCostRecoveryActionsMember2022-01-012022-03-310000059440us-gaap:OperatingSegmentsMembervgr:TobaccoSegmentMembervgr:HealthCareCostRecoveryActionsMember2021-01-012021-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
For The Quarterly Period Ended
March 31, 2022
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
VECTOR GROUP LTD.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
|
Delaware |
1-5759 |
65-0949535 |
(State or other jurisdiction of incorporation |
Commission File Number |
(I.R.S. Employer Identification No.) |
incorporation or organization) |
|
|
4400 Biscayne Boulevard
Miami, Florida 33137
305-579-8000
(Address, including zip code and telephone number, including area
code,
of the principal executive offices)
Securities Registered Pursuant to 12(b) of the Act:
|
|
|
|
|
|
|
|
|
Title of each class: |
Trading |
Name of each exchange |
|
Symbol(s) |
on which registered: |
Common stock, par value $0.10 per share |
VGR |
New York Stock Exchange |
Indicate
by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the Registrant was required to file such
reports), and (2) has been subject to such filing requirements for
the past 90 days.
x
Yes
o
No
Indicate
by check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant
was required to submit and post such files).
x
Yes
o
No
Indicate
by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of
“large accelerated filer,” “accelerated filer,” “smaller reporting
company,” and “emerging growth company” in Rule 12b-2 of the
Exchange Act.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
☒ |
Large accelerated filer |
☐ |
Accelerated filer |
☐ |
Non-accelerated filer |
☐ |
Smaller reporting company |
☐ |
Emerging Growth Company |
If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the
Exchange Act.
o
Indicate
by check mark whether the Registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act).
☐
Yes
x
No
At
May 6, 2022, Vector Group Ltd. had 154,938,177 shares of
common stock outstanding.
VECTOR GROUP LTD.
FORM 10-Q
TABLE OF CONTENTS
|
|
|
|
|
|
|
Page |
PART I. FINANCIAL INFORMATION |
|
|
|
Item 1. Vector Group Ltd. Condensed Consolidated Financial
Statements (Unaudited): |
|
|
|
Condensed Consolidated Balance Sheets as of March 31, 2022 and
December 31, 2021 |
|
|
|
Condensed Consolidated Statements of Operations for the three
months ended March 31, 2022 and 2021 |
|
|
|
Condensed Consolidated Statements of Comprehensive Income for the
three months ended March 31, 2022 and 2021 |
|
|
|
Condensed Consolidated Statements of Stockholders' Deficiency for
the three months ended March 31, 2022 and 2021 |
|
|
|
Condensed Consolidated Statements of Cash Flows for the three
months ended March 31, 2022 and 2021 |
|
|
|
Notes to Condensed Consolidated Financial Statements |
|
|
|
Item 2. Management’s Discussion and Analysis of Financial Condition
and Results of Operations |
|
|
|
Item 3. Quantitative and Qualitative Disclosures About Market
Risk |
|
|
|
Item 4. Controls and Procedures |
|
|
|
PART II. OTHER INFORMATION |
|
|
|
Item 1. Legal Proceedings |
|
|
|
Item 1A. Risk Factors |
|
|
|
Item 2. Unregistered Sales of Equity Securities and Use of
Proceeds |
|
|
|
Item 6. Exhibits |
|
|
|
SIGNATURE |
|
VECTOR GROUP LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars
in Thousands, Except Per Share Amounts)
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2022 |
|
December 31,
2021 |
ASSETS: |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ |
238,305 |
|
|
$ |
193,411 |
|
Investment securities at fair value |
133,338 |
|
|
146,687 |
|
|
|
|
|
Accounts receivable - trade, net |
29,885 |
|
|
16,067 |
|
Inventories |
97,991 |
|
|
94,615 |
|
Income taxes receivable, net |
— |
|
|
10,948 |
|
|
|
|
|
Other current assets |
8,103 |
|
|
10,075 |
|
Total current assets |
507,622 |
|
|
471,803 |
|
Property, plant and equipment, net |
36,079 |
|
|
36,883 |
|
Investments in real estate, net |
9,039 |
|
|
9,098 |
|
Long-term investments (includes $31,057 and $32,089 at fair
value)
|
49,799 |
|
|
53,073 |
|
Investments in real estate ventures |
111,503 |
|
|
105,062 |
|
|
|
|
|
Operating lease right-of-use assets |
10,133 |
|
|
10,972 |
|
Intangible assets |
107,511 |
|
|
107,511 |
|
Other assets |
80,884 |
|
|
76,685 |
|
Total assets |
$ |
912,570 |
|
|
$ |
871,087 |
|
LIABILITIES AND STOCKHOLDERS' DEFICIENCY: |
|
|
|
Current liabilities: |
|
|
|
Current portion of notes payable and long-term
debt |
$ |
76 |
|
|
$ |
79 |
|
|
|
|
|
Current payments due under the Master Settlement
Agreement
|
68,591 |
|
|
11,886 |
|
|
|
|
|
|
|
|
|
Income taxes payable, net |
3,462 |
|
|
— |
|
|
|
|
|
Current operating lease liability |
3,860 |
|
|
3,838 |
|
|
|
|
|
Other current liabilities |
139,961 |
|
|
149,487 |
|
Total current liabilities |
215,950 |
|
|
165,290 |
|
Notes payable, long-term debt and other obligations, less current
portion |
1,399,631 |
|
|
1,398,591 |
|
|
|
|
|
Non-current employee benefits |
69,164 |
|
|
68,970 |
|
Deferred income taxes, net |
31,307 |
|
|
34,768 |
|
Non-current operating lease liability |
7,885 |
|
|
8,853 |
|
Payments due under the Master Settlement Agreement |
11,116 |
|
|
13,224 |
|
|
|
|
|
Other liabilities |
18,169 |
|
|
22,944 |
|
Total liabilities |
1,753,222 |
|
|
1,712,640 |
|
Commitments and contingencies (Note 9) |
|
|
|
Stockholders' deficiency: |
|
|
|
Preferred stock, par value $1 per share, 10,000,000 shares
authorized
|
— |
|
|
— |
|
Common stock, par value $0.1 per share, 250,000,000 shares
authorized, 154,938,177 and 153,959,427 shares issued and
outstanding
|
15,494 |
|
|
15,396 |
|
Additional paid-in capital |
12,183 |
|
|
11,172 |
|
Accumulated deficit |
(852,863) |
|
|
(852,398) |
|
Accumulated other comprehensive loss |
(15,466) |
|
|
(15,723) |
|
|
|
|
|
Total Vector Group Ltd. stockholders' deficiency |
(840,652) |
|
|
(841,553) |
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' deficiency |
$ |
912,570 |
|
|
$ |
871,087 |
|
The accompanying notes are an integral part of the condensed
consolidated financial statements.
VECTOR GROUP LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Dollars
in Thousands, Except Per Share Amounts)
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
|
|
2022 |
|
2021 |
Revenues: |
|
|
|
|
|
|
|
Tobacco* |
|
|
|
|
$ |
309,048 |
|
|
$ |
268,463 |
|
Real estate |
|
|
|
|
2,994 |
|
|
2,525 |
|
|
|
|
|
|
|
|
|
Total
revenues |
|
|
|
|
312,042 |
|
|
270,988 |
|
|
|
|
|
|
|
|
|
Expenses: |
|
|
|
|
|
|
|
Cost of sales: |
|
|
|
|
|
|
|
Tobacco* |
|
|
|
|
211,537 |
|
|
164,031 |
|
Real estate |
|
|
|
|
1,278 |
|
|
876 |
|
|
|
|
|
|
|
|
|
Total cost of
sales |
|
|
|
|
212,815 |
|
|
164,907 |
|
|
|
|
|
|
|
|
|
Operating, selling, administrative and general expenses |
|
|
|
|
24,029 |
|
|
30,101 |
|
Litigation settlement and judgment expense |
|
|
|
|
72 |
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
|
|
|
|
75,126 |
|
|
75,975 |
|
|
|
|
|
|
|
|
|
Other income (expenses): |
|
|
|
|
|
|
|
Interest expense |
|
|
|
|
(25,098) |
|
|
(28,721) |
|
Loss on extinguishment of debt |
|
|
|
|
— |
|
|
(21,362) |
|
|
|
|
|
|
|
|
|
Equity in (losses) earnings from investments |
|
|
|
|
(2,242) |
|
|
577 |
|
Equity in (losses) earnings from real estate ventures |
|
|
|
|
(1,877) |
|
|
1,589 |
|
Other, net |
|
|
|
|
(1,145) |
|
|
2,706 |
|
Income before provision for income taxes |
|
|
|
|
44,764 |
|
|
30,764 |
|
Income tax expense |
|
|
|
|
12,222 |
|
|
9,214 |
|
Income from continuing operations |
|
|
|
|
32,542 |
|
|
21,550 |
|
Income from discontinued operations, net of income
taxes |
|
|
|
|
— |
|
|
10,407 |
|
Net income |
|
|
|
|
$ |
32,542 |
|
|
$ |
31,957 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Per basic common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income from continuing operations applicable to common
shares |
|
|
|
|
$ |
0.21 |
|
|
$ |
0.14 |
|
Net income from discontinued operations applicable to common
shares |
|
|
|
|
— |
|
|
0.06 |
|
Net income applicable to common shares |
|
|
|
|
$ |
0.21 |
|
|
$ |
0.20 |
|
|
|
|
|
|
|
|
|
Per diluted common share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income from continuing operations applicable to common
shares |
|
|
|
|
$ |
0.21 |
|
|
$ |
0.14 |
|
Net income from discontinued operations applicable to common
shares |
|
|
|
|
— |
|
|
0.06 |
|
Net income applicable to common shares |
|
|
|
|
$ |
0.21 |
|
|
$ |
0.20 |
|
*
Revenues and cost of sales include federal excise taxes of
$116,079, and $97,714 for the three months ended March 31, 2022
and
2021, respectively.
The accompanying notes are an integral part of the condensed
consolidated financial statements.
VECTOR GROUP LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE
INCOME
(Dollars
in Thousands)
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
|
|
2022 |
|
2021 |
|
|
|
|
Net income |
|
|
|
|
$ |
32,542 |
|
|
$ |
31,957 |
|
|
|
|
|
|
|
|
|
Net unrealized losses on investment securities available for
sale: |
|
|
|
|
|
|
|
Change in net unrealized losses |
|
|
|
|
(1,222) |
|
|
(182) |
|
Net unrealized losses (gains) reclassified into net
income |
|
|
|
|
1,165 |
|
|
(41) |
|
Net unrealized losses on investment securities available for
sale |
|
|
|
|
(57) |
|
|
(223) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in pension-related amounts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of loss |
|
|
|
|
404 |
|
|
482 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive income |
|
|
|
|
347 |
|
|
259 |
|
|
|
|
|
|
|
|
|
Income tax effect on: |
|
|
|
|
|
|
|
Change in net unrealized losses on investment
securities |
|
|
|
|
316 |
|
|
49 |
|
Net unrealized losses (gains) reclassified into net income on
investment securities |
|
|
|
|
(301) |
|
|
11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension-related amounts |
|
|
|
|
(105) |
|
|
(130) |
|
Income tax provision on other comprehensive income |
|
|
|
|
(90) |
|
|
(70) |
|
|
|
|
|
|
|
|
|
Other comprehensive income, net of tax |
|
|
|
|
257 |
|
|
189 |
|
|
|
|
|
|
|
|
|
Comprehensive income |
|
|
|
|
$ |
32,799 |
|
|
$ |
32,146 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the condensed
consolidated financial statements.
VECTOR GROUP LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’
DEFICIENCY
(Dollars
in Thousands, Except Share Amounts)
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vector Group Ltd. Stockholders' Deficiency |
|
|
|
|
|
|
|
Additional Paid-In |
|
|
|
Accumulated
Other Comprehensive |
|
|
|
|
|
|
|
Common Stock |
|
|
Accumulated |
|
|
|
|
|
|
|
Shares |
|
Amount |
|
Capital |
|
Deficit |
|
Loss |
|
|
|
|
|
Total |
Balance as of January 1, 2022 |
153,959,427 |
|
|
$ |
15,396 |
|
|
$ |
11,172 |
|
|
$ |
(852,398) |
|
|
$ |
(15,723) |
|
|
|
|
|
|
$ |
(841,553) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
— |
|
|
— |
|
|
— |
|
|
32,542 |
|
|
— |
|
|
|
|
|
|
32,542 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
257 |
|
|
|
|
|
|
257 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends on common stock ($0.20 per share)
|
— |
|
|
— |
|
|
— |
|
|
(31,767) |
|
|
— |
|
|
|
|
|
|
(31,767) |
|
Restricted stock grants |
1,070,000 |
|
|
107 |
|
|
(107) |
|
|
— |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Surrender of shares in connection with restricted stock
vesting |
(91,250) |
|
|
(9) |
|
|
(1,029) |
|
|
— |
|
|
— |
|
|
|
|
|
|
(1,038) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
— |
|
|
— |
|
|
2,147 |
|
|
— |
|
|
— |
|
|
|
|
|
|
2,147 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
— |
|
|
— |
|
|
— |
|
|
(1,240) |
|
|
— |
|
|
|
|
|
|
(1,240) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of March 31, 2022 |
154,938,177 |
|
|
$ |
15,494 |
|
|
$ |
12,183 |
|
|
$ |
(852,863) |
|
|
$ |
(15,466) |
|
|
|
|
|
|
$ |
(840,652) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vector Group Ltd. Stockholders' Deficiency |
|
|
|
|
|
|
|
Additional Paid-In |
|
|
|
Accumulated
Other Comprehensive |
|
|
|
|
|
|
|
Common Stock |
|
|
Accumulated |
|
|
|
|
|
|
|
Shares |
|
Amount |
|
Capital |
|
Deficit |
|
Loss |
|
|
|
|
|
Total |
Balance as of January 1, 2021 |
153,324,629 |
|
|
$ |
15,332 |
|
|
$ |
— |
|
|
$ |
(653,945) |
|
|
$ |
(21,074) |
|
|
|
|
|
|
$ |
(659,687) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
— |
|
|
— |
|
|
— |
|
|
31,957 |
|
|
— |
|
|
|
|
|
|
31,957 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
189 |
|
|
|
|
|
|
189 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends on common stock ($0.20 per share)
|
— |
|
|
— |
|
|
— |
|
|
(31,618) |
|
|
— |
|
|
|
|
|
|
(31,618) |
|
Restricted stock grant |
870,000 |
|
|
87 |
|
|
(87) |
|
|
— |
|
|
— |
|
|
|
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
— |
|
|
— |
|
|
2,660 |
|
|
— |
|
|
— |
|
|
|
|
|
|
2,660 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of March 31, 2021 |
154,194,629 |
|
|
$ |
15,419 |
|
|
$ |
2,573 |
|
|
$ |
(653,606) |
|
|
$ |
(20,885) |
|
|
|
|
|
|
$ |
(656,499) |
|
The accompanying notes are an integral part of the condensed
consolidated financial statements.
VECTOR GROUP LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars
in Thousands)
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
March 31, |
|
2022 |
|
2021 |
Net cash provided by operating activities |
$ |
74,796 |
|
|
$ |
78,364 |
|
Cash flows from investing activities: |
|
|
|
Sale of investment securities |
16,933 |
|
|
10,228 |
|
Maturities of investment securities |
21,105 |
|
|
13,968 |
|
Purchase of investment securities |
(27,231) |
|
|
(38,441) |
|
Proceeds from sale or liquidation of long-term
investments |
— |
|
|
4,389 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase of long-term investments |
(1,000) |
|
|
(5,813) |
|
Investments in real estate ventures |
(8,488) |
|
|
(8,087) |
|
Distributions from investments in real estate ventures |
3,310 |
|
|
7,577 |
|
Increase in cash surrender value of life insurance
policies |
(765) |
|
|
(564) |
|
Increase in restricted assets |
— |
|
|
(3) |
|
|
|
|
|
|
|
|
|
Capital expenditures |
(1,222) |
|
|
(1,931) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Paydowns of investment securities |
63 |
|
|
172 |
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities |
2,705 |
|
|
(18,505) |
|
Cash flows from financing activities: |
|
|
|
Proceeds from issuance of debt |
— |
|
|
875,000 |
|
Deferred financing costs |
— |
|
|
(20,000) |
|
Repayments of debt |
(11) |
|
|
(853,158) |
|
Borrowings under revolving credit facility |
67,298 |
|
|
259 |
|
Repayments on revolving credit facility |
(67,298) |
|
|
(259) |
|
Dividends on common stock |
(31,658) |
|
|
(32,273) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
(938) |
|
|
(21) |
|
Net cash used in financing activities |
(32,607) |
|
|
(30,452) |
|
Net increase in cash, cash equivalents and restricted
cash |
44,894 |
|
|
29,407 |
|
Cash, cash equivalents and restricted cash, beginning of
period |
194,849 |
|
|
365,677 |
|
Cash, cash equivalents and restricted cash, end of
period |
$ |
239,743 |
|
|
$ |
395,084 |
|
The accompanying notes are an integral part of the condensed
consolidated financial statements.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
1. SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES
(a)Basis
of Presentation:
The condensed consolidated financial statements of Vector Group
Ltd. (the “Company” or “Vector”) include the accounts of Liggett
Group LLC (“Liggett”), Vector Tobacco LLC (“Vector Tobacco”),
Liggett Vector Brands LLC (“Liggett Vector Brands”), New Valley LLC
(“New Valley”) and other less significant subsidiaries. New Valley
includes the accounts of other less significant subsidiaries. All
significant intercompany balances and transactions have been
eliminated.
Liggett and Vector Tobacco are engaged in the manufacture and sale
of cigarettes in the United States. Liggett Vector Brands
coordinates Liggett and Vector Tobacco’s sales and marketing
efforts. Certain references to “Liggett” refer to the Company’s
tobacco operations, including the business of Liggett and Vector
Tobacco, unless otherwise specified. New Valley is engaged in the
real estate business.
The unaudited, interim condensed consolidated financial statements
have been prepared in accordance with U.S. generally accepted
accounting principles (“U.S. GAAP”) for interim financial
information and, in management’s opinion, contain all adjustments,
consisting only of normal recurring items, necessary for a fair
statement of the results for the periods presented. Accordingly,
they do not include all of the information and footnotes required
by U.S. GAAP for complete financial statements. These
condensed consolidated financial statements should be read in
conjunction with the consolidated financial statements included in
the Company’s Annual Report on Form 10-K for the year ended
December 31, 2021 filed with the Securities and Exchange
Commission (“SEC”). The consolidated results of operations for
interim periods should not be regarded as necessarily indicative of
the results that may be expected for the entire year.
(b)Distributions
and Dividends on Common Stock:
The Company records distributions on its common stock as dividends
in its condensed consolidated statements of stockholders’
deficiency to the extent of retained earnings. Any amounts
exceeding retained earnings are recorded as a reduction to
additional paid-in capital to the extent paid-in-capital is
available and then to accumulated deficit.
(c)Earnings
Per Share (“EPS”):
Net income for purposes of determining basic and diluted EPS for
discontinued operations and net income available to common
stockholders was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
|
|
2022 |
|
2021 |
Net income from continuing operations |
|
|
|
|
$ |
32,542 |
|
|
$ |
21,550 |
|
Net income from discontinued operations |
|
|
|
|
— |
|
|
10,407 |
|
Net income |
|
|
|
|
32,542 |
|
|
31,957 |
|
Income from continuing operations attributable to participating
securities |
|
|
|
|
(983) |
|
|
(776) |
|
Net income applicable to common shares |
|
|
|
|
$ |
31,559 |
|
|
$ |
31,181 |
|
Net income for purposes of determining basic and diluted EPS for
continuing operations applicable to common shares was as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
|
|
2022 |
|
2021 |
Net income from continuing operations |
|
|
|
|
$ |
32,542 |
|
|
$ |
21,550 |
|
Income from continuing operations attributable to participating
securities |
|
|
|
|
(983) |
|
|
(754) |
|
Net income available to common stockholders |
|
|
|
|
$ |
31,559 |
|
|
$ |
20,796 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Basic and diluted EPS for continuing and discontinued operations
were calculated using the following common shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
|
|
2022 |
|
2021 |
Weighted-average shares for basic EPS |
|
|
|
|
152,586,900 |
|
|
152,249,440 |
|
|
|
|
|
|
|
|
|
Plus incremental shares related to stock options and non-vested
restricted stock |
|
|
|
|
158,353 |
|
|
134,650 |
|
Weighted-average shares for diluted EPS |
|
|
|
|
152,745,253 |
|
|
152,384,090 |
|
It may not be possible to recalculate EPS attributable to common
stockholders by adjusting EPS from continuing operations by EPS
from discontinued operations as each amount is calculated
independently.
The following non-vested restricted stock was outstanding during
the three months ended March 31, 2022 and 2021, but was not
included in the computation of diluted EPS because the impact of
the per share expense associated with the restricted stock was
greater than the average market price of the common shares during
the respective periods.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
|
|
2022 |
|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares of non-vested restricted
stock |
|
|
|
|
— |
|
|
97,222 |
|
Weighted-average expense per share |
|
|
|
|
$ |
— |
|
|
$ |
14.31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(d)Other,
net:
Other, net consisted of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
|
|
2022 |
|
2021 |
|
|
|
|
|
|
|
|
Interest and dividend income |
|
|
|
|
$ |
450 |
|
|
$ |
534 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (losses) gains recognized on investment securities |
|
|
|
|
(3,039) |
|
|
2,415 |
|
Net periodic benefit cost other than the service costs |
|
|
|
|
(236) |
|
|
(244) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income |
|
|
|
|
1,680 |
|
|
1 |
|
Other, net |
|
|
|
|
$ |
(1,145) |
|
|
$ |
2,706 |
|
(e)Other
Assets:
Other assets consisted of:
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2022 |
|
December 31, 2021 |
Restricted assets |
$ |
1,551 |
|
|
$ |
1,551 |
|
Prepaid pension costs |
44,866 |
|
|
44,585 |
|
Other assets |
34,467 |
|
|
30,549 |
|
Total other assets |
$ |
80,884 |
|
|
$ |
76,685 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
(f)Other
Current Liabilities:
Other current liabilities consisted of:
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2022 |
|
December 31, 2021 |
Accounts payable |
$ |
7,453 |
|
|
$ |
9,443 |
|
Accrued promotional expenses |
57,610 |
|
|
55,647 |
|
Accrued excise and payroll taxes payable, net |
21,375 |
|
|
22,919 |
|
Accrued interest |
32,667 |
|
|
30,676 |
|
Accrued salaries and benefits |
4,042 |
|
|
13,982 |
|
Allowance for sales returns |
6,063 |
|
|
6,669 |
|
Other current liabilities |
10,751 |
|
|
10,151 |
|
Total other current liabilities |
$ |
139,961 |
|
|
$ |
149,487 |
|
(g)Reconciliation
of Cash, Cash Equivalents and Restricted Cash:
The components of “Cash, cash equivalents and restricted cash” in
the condensed consolidated statements of cash flows were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2022 |
|
December 31,
2021 |
Cash and cash equivalents
|
$ |
238,305 |
|
|
$ |
193,411 |
|
|
|
|
|
Restricted cash and cash equivalents included in other
assets |
1,438 |
|
|
1,438 |
|
Total cash, cash equivalents, and restricted cash shown in the
condensed consolidated statements of cash flows
|
$ |
239,743 |
|
|
$ |
194,849 |
|
(h)Related
Party Transactions:
Agreements with Douglas Elliman.
The Company received $1,050 under the Transition Services Agreement
and $491 under the Aircraft Lease Agreement during the
three months ended March 31, 2022.
Real estate venture investments.
Douglas Elliman has been engaged by the developers as the sole
broker or the co-broker for several of the real estate development
projects that New Valley owns an interest in through its real
estate venture investments. Douglas Elliman had gross commissions
of approximately $900 and $2,357 from these projects for the three
months ended March 31, 2022 and 2021,
respectively.
(i)New
Accounting Pronouncements:
ASUs to be adopted in future periods:
In October 2021, the FASB issued
ASU 2021-08, Business Combinations (Topic 805), Accounting for
Contract Assets and Contract Liabilities from Contracts with
Customers.
The ASU requires that an acquirer recognize and measure contract
assets and contract liabilities in a business combination in
accordance with Topic 606. The ASU is effective for fiscal years
beginning after December 15, 2022, including interim periods within
those fiscal years. The Company is currently evaluating the impact
of the new guidance on its consolidated financial
statements.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
2. REVENUE
RECOGNITION
Disaggregation of Revenue
The Company disaggregates revenues by segment.
Tobacco.
Tobacco segment revenues are not disaggregated because all revenues
are generated from the discount segment of the U.S. cigarette
industry.
Real Estate.
Real Estate segment revenues are disaggregated in the table
below.
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
March 31, |
|
2022 |
|
2021 |
Real Estate Segment Revenues |
|
|
|
Sales on facilities primarily from Escena |
$ |
2,969 |
|
|
$ |
1,625 |
|
Revenues from investments in real estate |
25 |
|
|
900 |
|
Total real estate revenues |
$ |
2,994 |
|
|
$ |
2,525 |
|
3. LEASES
The Company has operating and finance leases for corporate and
sales offices, and certain vehicles and equipment. The components
of lease expense were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
|
|
2022 |
|
2021 |
Operating lease cost |
|
|
|
|
$ |
1,125 |
|
|
$ |
1,166 |
|
Short-term lease cost
|
|
|
|
|
103 |
|
|
91 |
|
Variable lease cost
|
|
|
|
|
56 |
|
|
52 |
|
|
|
|
|
|
|
|
|
Finance lease cost:
|
|
|
|
|
|
|
|
Amortization
|
|
|
|
|
14 |
|
|
16 |
|
Interest on lease liabilities
|
|
|
|
|
2 |
|
|
3 |
|
Total lease cost
|
|
|
|
|
$ |
1,300 |
|
|
$ |
1,328 |
|
|
|
|
|
|
|
|
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Supplemental cash flow information related to leases was as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
March 31, |
|
|
2022 |
|
2021 |
|
Cash paid for amounts included in measurement of lease
liabilities: |
|
|
|
|
Operating cash flows from operating leases
|
$ |
1,235 |
|
|
$ |
1,266 |
|
|
Operating cash flows from finance leases
|
2 |
|
|
3 |
|
|
Financing cash flows from finance leases
|
14 |
|
|
15 |
|
|
|
|
|
|
|
Right-of-use assets obtained in exchange for lease
obligations:
|
|
|
|
|
Operating leases
|
— |
|
|
7 |
|
|
Finance leases
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
As of March 31, 2022, the Company had $120 in undiscounted
lease payments relating to operating leases for equipment that have
not yet commenced. The operating leases will commence in the second
half of 2022 with lease terms ranging between 2 and 3
years.
4. DISCONTINUED
OPERATIONS
On December 29, 2021, the Company completed the distribution to its
stockholders (including Vector common stock underlying outstanding
stock options awards and restricted stock awards) of the common
stock of Douglas Elliman Inc. (the “Distribution”).
There were no assets or liabilities of discontinued operations of
Douglas Elliman as of March 31, 2022 or December 31,
2021.
The financial results of Douglas Elliman through the completion of
the Distribution are presented as income from discontinued
operations, net of income taxes on the Company’s condensed
consolidated statements of operations. The following table presents
financial results of Douglas Elliman for the periods prior to the
completion of the Distribution:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
2022 |
|
2021 |
|
|
|
(Dollars in thousands) |
Revenues: |
|
|
|
|
|
Real estate |
$ |
— |
|
|
$ |
272,776 |
|
|
|
|
|
|
|
|
|
Expenses: |
|
|
|
|
|
Cost of sales |
— |
|
|
198,635 |
|
|
|
|
|
|
|
|
|
Operating, selling, administrative and general expenses |
— |
|
|
59,913 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income |
— |
|
|
14,228 |
|
|
|
|
|
|
|
|
|
Other income (expenses): |
|
|
|
|
|
Interest expense |
— |
|
|
(30) |
|
|
|
|
|
|
|
|
|
Other, net |
— |
|
|
48 |
|
|
|
Pretax income from discontinued operations |
— |
|
|
14,246 |
|
|
|
Income tax expense |
— |
|
|
3,839 |
|
|
|
Income from discontinued operations |
$ |
— |
|
|
$ |
10,407 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
The following table presents the information regarding certain
components of cash flows from discontinued operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
2022 |
|
2021 |
|
|
|
(Dollars in thousands) |
Depreciation and amortization |
$ |
— |
|
|
$ |
2,123 |
|
|
|
Non-cash lease expense |
— |
|
|
4,487 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures |
— |
|
|
(597) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5. INVENTORIES
Inventories consisted of:
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2022 |
|
December 31,
2021 |
Leaf tobacco |
$ |
40,483 |
|
|
$ |
38,825 |
|
Other raw materials |
9,115 |
|
|
7,560 |
|
Work-in-process |
692 |
|
|
2,639 |
|
|
|
|
|
Finished goods |
66,328 |
|
|
64,218 |
|
|
|
|
|
Inventories at current cost |
116,618 |
|
|
113,242 |
|
LIFO adjustments |
(18,627) |
|
|
(18,627) |
|
|
$ |
97,991 |
|
|
$ |
94,615 |
|
All of the Company’s inventories at March 31, 2022 and
December 31, 2021 are reported under the LIFO method. The
$18,627 LIFO adjustment as of March 31, 2022 reduced the
current cost of inventories by $12,128 for Leaf tobacco, $829 for
Other raw materials, $18 for Work-in-process and $5,652 for
Finished goods. The $18,627 LIFO adjustment as of December 31,
2021 reduced the current cost of inventories by $12,128 for Leaf
tobacco, $829 for Other raw materials, $18 for Work-in-process and
$5,652 for Finished goods.
The amount of capitalized Master Settlement Agreement (“MSA”) cost
in “Finished goods” inventory was $20,971 and $20,450 at
March 31, 2022 and December 31, 2021, respectively.
Federal excise tax capitalized in inventory was $26,021 and $25,160
at March 31, 2022 and December 31, 2021,
respectively.
At March 31, 2022, Liggett had tobacco purchase commitments of
approximately $8,293. Liggett has a single-source supply agreement
for reduced ignition propensity cigarette paper through December
2022.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
6. INVESTMENT
SECURITIES
Investment securities consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2022 |
|
December 31, 2021 |
Debt securities available for sale |
$ |
91,838 |
|
|
$ |
103,906 |
|
|
|
|
|
|
|
|
|
Equity securities at fair value: |
|
|
|
Marketable equity securities |
18,962 |
|
|
19,560 |
|
Mutual funds invested in debt securities |
22,538 |
|
|
23,221 |
|
Long-term investment securities at fair value
(1)
|
31,057 |
|
|
32,089 |
|
Total
equity securities at fair value |
72,557 |
|
|
74,870 |
|
|
|
|
|
Total investment securities at fair value |
164,395 |
|
|
178,776 |
|
Less: |
|
|
|
Long-term investment securities at fair value
(1)
|
31,057 |
|
|
32,089 |
|
Current investment securities at fair value |
$ |
133,338 |
|
|
$ |
146,687 |
|
|
|
|
|
Long-term investment securities at fair value
(1)
|
$ |
31,057 |
|
|
$ |
32,089 |
|
Equity-method investments |
18,742 |
|
|
20,984 |
|
Total long-term investments |
$ |
49,799 |
|
|
$ |
53,073 |
|
|
|
|
|
Equity securities at cost
(2)
|
$ |
6,200 |
|
|
$ |
5,200 |
|
|
|
|
|
|
|
|
|
(1)
These assets are measured at net asset value (“NAV”) as a practical
expedient under ASC 820.
(2)
These
assets
are without readily determinable fair values that do not qualify
for the NAV practical expedient and are included in Other assets on
the condensed consolidated balance sheets.
Net (losses) gains recognized on investment securities were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
|
|
2022 |
|
2021 |
Net (losses) gains recognized on equity securities |
|
|
|
|
$ |
(1,874) |
|
|
$ |
2,374 |
|
Net gains recognized on debt securities available for
sale |
|
|
|
|
— |
|
|
55 |
|
|
|
|
|
|
|
|
|
Impairment expense |
|
|
|
|
(1,165) |
|
|
(14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (losses) gains recognized on investment securities |
|
|
|
|
$ |
(3,039) |
|
|
$ |
2,415 |
|
(a) Debt Securities Available for Sale:
The components of debt securities available for sale at
March 31, 2022 were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost |
|
Gross
Unrealized
Gains |
|
Gross
Unrealized
Losses |
|
Fair
Value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketable debt securities |
$ |
91,827 |
|
|
$ |
11 |
|
|
$ |
— |
|
|
$ |
91,838 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
The table below summarizes the maturity dates of debt securities
available for sale at March 31, 2022.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Type: |
Fair Value |
|
Under 1 Year |
|
1 Year up to 5 Years |
|
More than 5 Years |
U.S. Government securities |
$ |
5,585 |
|
|
$ |
4,805 |
|
|
$ |
780 |
|
|
$ |
— |
|
Corporate securities |
55,324 |
|
|
30,317 |
|
|
25,007 |
|
|
— |
|
U.S. mortgage-backed securities |
19,173 |
|
|
1,793 |
|
|
17,380 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial paper |
10,540 |
|
|
10,540 |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
Foreign fixed-income securities |
1,216 |
|
|
1,216 |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
Total debt securities available for sale by maturity
dates
|
$ |
91,838 |
|
|
$ |
48,671 |
|
|
$ |
43,167 |
|
|
$ |
— |
|
The components of debt securities available for sale at
December 31, 2021 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost |
|
Gross
Unrealized
Gains |
|
Gross
Unrealized
Losses |
|
Fair
Value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Marketable debt securities |
$ |
103,838 |
|
|
$ |
68 |
|
|
$ |
— |
|
|
$ |
103,906 |
|
|
|
|
|
|
|
|
|
There were no available-for-sale debt securities with continuous
unrealized losses for less than 12 months and 12 months or greater
at March 31, 2022 and December 31, 2021,
respectively.
Gross realized gains and losses on debt securities available for
sale were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
|
|
2022 |
|
2021 |
Gross realized gains on sales |
|
|
|
|
$ |
1 |
|
|
$ |
56 |
|
Gross realized losses on sales |
|
|
|
|
(1) |
|
|
(1) |
|
Net gains recognized on debt securities available for
sale |
|
|
|
|
$ |
— |
|
|
$ |
55 |
|
|
|
|
|
|
|
|
|
Impairment expense |
|
|
|
|
$ |
(1,165) |
|
|
$ |
(14) |
|
|
|
|
|
|
|
|
|
Although management generally does not have the intent to sell any
specific securities at the end of the period, in the ordinary
course of managing the Company’s investment securities portfolio,
management may sell securities prior to their maturities for a
variety of reasons, including diversification, credit quality,
yield and liquidity requirements.
(b) Equity Securities at Fair Value:
The following is a summary of unrealized and realized net losses
and gains recognized in net income on equity securities at fair
value during the three and three months ended March 31, 2022 and
2021, respectively:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
|
|
2022 |
|
2021 |
Net (losses) gains recognized on equity securities |
|
|
|
|
$ |
(1,874) |
|
|
$ |
2,374 |
|
Less: Net gains recognized on equity securities sold |
|
|
|
|
293 |
|
|
169 |
|
Net unrealized (losses) gains recognized on equity securities still
held at the reporting date |
|
|
|
|
$ |
(2,167) |
|
|
$ |
2,205 |
|
|
|
|
|
|
|
|
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
The Company’s mutual funds invested in debt securities are
classified as Level 1 under the fair value hierarchy disclosed in
Note 11. Their fair values are based on quoted prices for identical
assets in active markets or inputs that are based upon quoted
prices for similar instruments in active markets. The Company has
unfunded commitments of $514 related to long-term investment
securities at fair value as of March 31, 2022.
The Company received cash distributions of $202 and $4,389 related
to its long-term investment securities at fair value for the three
months ended March 31, 2022 and 2021, respectively. The
Company classified the $202 distributions as operating cash inflows
for the three months ended March 31, 2022 and the $4,389
distributions as investing cash inflows for the three months ended
March 31, 2021.
(c) Equity-Method Investments:
Equity-method investments consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2022 |
|
December 31, 2021 |
Mutual fund and hedge funds |
$ |
18,742 |
|
|
$ |
20,984 |
|
|
|
|
|
|
|
|
|
At March 31, 2022, the Company’s ownership percentages in the
mutual fund and hedge funds accounted for under the equity method
ranged from 6.45% to 37.70%. The Company’s ownership percentage in
these investments meets the threshold for equity-method
accounting.
Equity in (losses) earnings from investments were:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
|
|
2022 |
|
2021 |
Mutual fund and hedge funds |
|
|
|
|
$ |
(2,242) |
|
|
$ |
577 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(d) Equity Securities Without Readily Determinable Fair Values That
Do Not Qualify for the NAV Practical Expedient
Equity securities without readily determinable fair values that do
not qualify for the NAV practical expedient consisted of
investments in various limited liability companies at
March 31, 2022 and December 31, 2021, respectively. The
total carrying value of these investments was $6,200 as of
March 31, 2022 and $5,200 as of December 31, 2021, and
was included in “Other assets” on the condensed consolidated
balance sheets. No impairment or other adjustments related to
observable price changes in orderly transactions for identical or
similar investments were identified for the three months ended
March 31, 2022 and 2021, respectively.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
7.
NEW VALLEY LLC
Investments in real estate ventures:
The components of “Investments in real estate ventures” were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Range of Ownership
(1)
|
|
March 31, 2022 |
|
December 31, 2021 |
Condominium and Mixed Use Development: |
|
|
|
|
|
New
York City Standard Metropolitan Statistical Area
(“SMSA”) |
4.2% - 37.0%
|
|
$ |
21,266 |
|
|
$ |
22,654 |
|
All
other U.S. areas |
19.6% - 89.1%
|
|
60,359 |
|
|
57,485 |
|
|
|
|
81,625 |
|
|
80,139 |
|
Apartment Buildings: |
|
|
|
|
|
|
|
|
|
|
|
All
other U.S. areas |
50.0% |
|
11,391 |
|
|
11,900 |
|
|
|
|
11,391 |
|
|
11,900 |
|
Hotels: |
|
|
|
|
|
New
York City SMSA |
0.4% - 12.3%
|
|
1,347 |
|
|
1,635 |
|
International |
49.0% |
|
1,259 |
|
|
1,522 |
|
|
|
|
2,606 |
|
|
3,157 |
|
Commercial: |
|
|
|
|
|
New
York City SMSA |
49.0% |
|
8,070 |
|
|
— |
|
All
other U.S. areas |
1.6% |
|
7,444 |
|
|
7,290 |
|
|
|
|
15,514 |
|
|
7,290 |
|
|
|
|
|
|
|
Other: |
15.0% - 49.0%
|
|
367 |
|
|
2,576 |
|
Investments in real estate ventures |
|
|
$ |
111,503 |
|
|
$ |
105,062 |
|
_____________________________
(1)
The Range of Ownership reflects New Valley’s estimated current
ownership percentage. New Valley’s actual ownership percentage as
well as the percentage of earnings and cash distributions may
ultimately differ as a result of a number of factors including
potential dilution, financing or admission of additional
partners.
Contributions:
The components of New Valley’s contributions to its investments in
real estate ventures were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
March 31, |
|
2022 |
|
2021 |
Condominium and Mixed Use Development: |
|
|
|
New
York City SMSA |
$ |
369 |
|
|
$ |
180 |
|
All
other U.S. areas |
— |
|
|
6,661 |
|
|
369 |
|
|
6,841 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hotels: |
|
|
|
New
York City SMSA |
49 |
|
|
1,246 |
|
|
|
|
|
|
49 |
|
|
1,246 |
|
Commercial: |
|
|
|
New
York City SMSA |
8,070 |
|
|
— |
|
|
|
|
|
|
8,070 |
|
|
— |
|
|
|
|
|
|
|
|
|
Total contributions |
$ |
8,488 |
|
|
$ |
8,087 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
For ventures where New Valley previously held an investment, New
Valley contributed its proportionate share of additional capital
along with contributions by the other investment partners during
the three months ended March 31, 2022 and March 31, 2021.
New Valley’s direct investment percentage for these ventures did
not significantly change.
Distributions:
The components of distributions received by New Valley from its
investments in real estate ventures were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
March 31, |
|
2022 |
|
2021 |
Condominium and Mixed Use Development: |
|
|
|
New
York City SMSA |
$ |
900 |
|
|
$ |
— |
|
All
other U.S. areas |
— |
|
|
2,833 |
|
|
900 |
|
|
2,833 |
|
Apartment Buildings: |
|
|
|
|
|
|
|
All
other U.S. areas |
200 |
|
|
4,608 |
|
|
200 |
|
|
4,608 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial: |
|
|
|
|
|
|
|
All
other U.S. areas |
218 |
|
|
136 |
|
|
218 |
|
|
136 |
|
|
|
|
|
Other |
2,725 |
|
|
— |
|
Total distributions |
$ |
4,043 |
|
|
$ |
7,577 |
|
Of the distributions received by New Valley from its investment in
real estate ventures, $733 were from distributions of earnings for
the three months ended March 31, 2022, and $3,310 and $7,577
were a return of capital for the three months ended March 31,
2022 and 2021, respectively. Distributions from earnings are
included in cash from operations in the condensed consolidated
statements of cash flows, while distributions from return of
capital are included in cash flows from investing activities in the
condensed consolidated statements of cash flows.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Equity in Earnings (losses) from Real Estate Ventures:
New Valley recognized equity in (losses) earnings from real estate
ventures as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
March 31, |
|
|
|
|
|
|
2022 |
|
2021 |
|
Condominium and Mixed Use Development: |
|
|
|
|
|
|
|
|
New
York City SMSA |
|
|
|
|
$ |
(1,216) |
|
|
$ |
(1,505) |
|
|
All
other U.S. areas |
|
|
|
|
(482) |
|
|
(41) |
|
|
|
|
|
|
|
(1,698) |
|
|
(1,546) |
|
|
Apartment Buildings: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All
other U.S. areas |
|
|
|
|
(309) |
|
|
4,608 |
|
|
|
|
|
|
|
(309) |
|
|
4,608 |
|
|
Hotels: |
|
|
|
|
|
|
|
|
New
York City SMSA |
|
|
|
|
(494) |
|
|
(462) |
|
|
International |
|
|
|
|
(263) |
|
|
(506) |
|
|
|
|
|
|
|
(757) |
|
|
(968) |
|
|
Commercial: |
|
|
|
|
|
|
|
|
New
York City SMSA |
|
|
|
|
— |
|
|
122 |
|
|
All
other U.S. areas |
|
|
|
|
372 |
|
|
93 |
|
|
|
|
|
|
|
372 |
|
|
215 |
|
|
|
|
|
|
|
|
|
|
|
Other: |
|
|
|
|
515 |
|
|
(720) |
|
|
Equity in (losses) earnings from real estate ventures |
|
|
|
|
$ |
(1,877) |
|
|
$ |
1,589 |
|
|
VIE Consideration:
The Company has determined that New Valley is the primary
beneficiary of one real estate venture because it controls the
activities that most significantly impact the economic performance
of the real estate venture. Consequently, New Valley consolidates
this variable interest entity (“VIE”).
The carrying amount of the consolidated assets of the VIE was
$0 at both March 31, 2022 and December 31,
2021. Those assets are owned by the VIE, not the Company. The
consolidated VIE had no recourse liabilities as
of March 31, 2022 and December 31, 2021. A
VIE’s assets can only be used to settle the obligations of that
VIE. The VIE is not a guarantor of the Company’s senior notes and
other debts payable.
For the remaining investments in real estate ventures, New Valley
determined that the entities were VIEs but New Valley was not the
primary beneficiary. Therefore, New Valley’s investment in such
real estate ventures has been accounted for under the equity method
of accounting.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Maximum Exposure to Loss:
New Valley’s maximum exposure to loss from its investments in real
estate ventures consisted of the net carrying value of the venture
adjusted for any future capital commitments and/or guarantee
arrangements. The maximum exposure to loss was as
follows:
|
|
|
|
|
|
|
March 31, 2022 |
Condominium and Mixed Use Development: |
|
New
York City SMSA |
$ |
21,266 |
|
All
other U.S. areas |
60,359 |
|
|
81,625 |
|
Apartment Buildings: |
|
|
|
All
other U.S. areas |
11,391 |
|
|
11,391 |
|
Hotels: |
|
New
York City SMSA |
1,347 |
|
International |
1,259 |
|
|
2,606 |
|
Commercial: |
|
New
York City SMSA |
8,070 |
|
All
other U.S. areas |
7,444 |
|
|
15,514 |
|
|
|
Other |
367 |
|
Total maximum exposure to loss |
$ |
111,503 |
|
New Valley capitalized $3,716 and $430 of interest costs into the
carrying value of its ventures whose projects were currently under
development for three months ended March 31, 2022 and 2021,
respectively.
Combined Financial Statements for Unconsolidated Subsidiaries
Accounted for under the Equity Method:
Pursuant to Rule 4-08(g), the following summarized financial data
for unconsolidated subsidiaries includes information for the
following: Other (Witkoff GP Partners).
Other:
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
March 31, |
|
2022 |
|
2021 |
Income Statement |
|
|
|
Revenue |
$ |
— |
|
|
$ |
21 |
|
Other expenses |
2,829 |
|
|
300,829 |
|
Loss from continuing operations |
$ |
(2,829) |
|
|
$ |
(300,808) |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Investments in Real Estate, net:
The components of “Investments in real estate, net” were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2022 |
|
December 31,
2021 |
Escena, net |
$ |
9,039 |
|
|
$ |
9,098 |
|
|
|
|
|
|
|
|
|
Investments
in real estate, net |
$ |
9,039 |
|
|
$ |
9,098 |
|
Escena. The
assets of “Escena, net” were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2022 |
|
December 31,
2021 |
Land and land improvements |
$ |
8,520 |
|
|
$ |
8,520 |
|
Building and building improvements |
1,926 |
|
|
1,926 |
|
Other |
1,636 |
|
|
1,643 |
|
|
12,082 |
|
|
12,089 |
|
Less accumulated depreciation |
(3,043) |
|
|
(2,991) |
|
|
$ |
9,039 |
|
|
$ |
9,098 |
|
New Valley recorded operating income of $1,239 and $370 for the
three months ended March 31, 2022 and 2021, respectively, from
Escena. Escena is a master planned community, golf course, and club
house in Palm Springs, California. In April 2022, New Valley sold
Escena and received approximately $15,300 in net cash proceeds. The
Company will account for the transaction in its condensed
consolidated statement of operations for the three months ended
June 30, 2022.
8. NOTES
PAYABLE, LONG-TERM DEBT AND OTHER OBLIGATIONS
Notes payable, long-term debt and other obligations consisted
of:
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2022 |
|
December 31,
2021 |
Vector: |
|
|
|
5.75% Senior Secured Notes due 2029
|
$ |
875,000 |
|
|
$ |
875,000 |
|
|
|
|
|
10.5% Senior Notes due 2026, net of unamortized discount of $2,543
and $2,647
|
552,457 |
|
|
552,353 |
|
|
|
|
|
Liggett: |
|
|
|
Revolving credit facility
|
24 |
|
|
24 |
|
|
|
|
|
Equipment loans
|
58 |
|
|
64 |
|
Other |
24 |
|
|
32 |
|
Notes payable, long-term debt and other obligations |
1,427,563 |
|
|
1,427,473 |
|
Less: |
|
|
|
Debt issuance costs
|
(27,856) |
|
|
(28,803) |
|
Total notes payable, long-term debt and other
obligations |
1,399,707 |
|
|
1,398,670 |
|
Less: |
|
|
|
Current maturities |
(76) |
|
|
(79) |
|
Amount due after one year |
$ |
1,399,631 |
|
|
$ |
1,398,591 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
5.75% Senior Secured Notes due 2029 — Vector:
As of March 31, 2022, the Company was in compliance with all
debt covenants related to its 5.75% Senior Secured Notes due
2029.
6.125% Senior Secured Notes due 2025 — Vector:
On February 1, 2021, the 6.125% Senior Secured Notes due 2025 were
redeemed in full and the Company recorded a loss on the
extinguishment of debt of $21,362 for the three months ended March
31, 2021, including $13,013 of premium and $8,349 of other costs
and non-cash interest expense related to the recognition of
previously unamortized deferred finance costs.
10.5% Senior Notes due 2026 — Vector:
As of March 31, 2022, the Company was in compliance with all
debt covenants related to its 10.5% Senior Notes due
2026.
Revolving Credit Agreement — Liggett:
As of March 31, 2022, there was $24 outstanding balance due
under the Credit Agreement. Availability, as determined under the
Credit Agreement, was approximately $83,500 based on eligible
collateral at March 31, 2022. As of March 31, 2022,
Liggett, Maple, and Vector Tobacco were in compliance with all debt
covenants under the Credit Agreement.
Non-Cash Interest Expense — Vector:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
|
|
2022 |
|
2021 |
Amortization of debt discount, net |
|
|
|
|
$ |
105 |
|
|
$ |
94 |
|
Amortization of debt issuance costs |
|
|
|
|
998 |
|
|
893 |
|
Loss on extinguishment of 6.125% Senior Secured Notes
|
|
|
|
|
— |
|
|
8,349 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,103 |
|
|
$ |
9,336 |
|
Fair Value of Notes Payable and Long-Term Debt:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2022 |
|
December 31, 2021 |
|
Carrying |
|
Fair |
|
Carrying |
|
Fair |
|
Value |
|
Value |
|
Value |
|
Value |
Senior Notes |
$ |
1,427,457 |
|
|
$ |
1,361,869 |
|
|
$ |
1,427,353 |
|
|
$ |
1,426,176 |
|
|
|
|
|
|
|
|
|
Liggett and other |
106 |
|
|
108 |
|
|
120 |
|
|
124 |
|
Notes payable and long-term debt |
$ |
1,427,563 |
|
|
$ |
1,361,977 |
|
|
$ |
1,427,473 |
|
|
$ |
1,426,300 |
|
|
|
|
|
|
|
|
|
Notes payable and long-term debt are carried on the condensed
consolidated balance sheets at amortized cost. The fair value
determinations disclosed above are classified as Level 2 under the
fair value hierarchy disclosed in Note 11 if such liabilities were
recorded on the condensed consolidated balance sheets at fair
value. The estimated fair value of the Company’s notes payable and
long-term debt has been determined by the Company using available
market information and appropriate valuation methodologies
including the evaluation of the Company’s credit risk. The Company
used a derived price based upon quoted market prices and trade
activity as of March 31, 2022 to determine the fair value of
its publicly-traded notes and debentures. The carrying value of the
revolving credit facility is equal to fair value. The fair value of
the equipment loans and other obligations was determined by
calculating the present value of the required future cash flows.
However, considerable judgment is required to develop the estimates
of fair value and, accordingly, the estimate presented herein is
not necessarily indicative of the amount that could be realized in
a current market exchange.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
9. CONTINGENCIES
Tobacco-Related Litigation:
Overview.
Since 1954, Liggett and other United States cigarette manufacturers
have been named as defendants in numerous direct, third-party and
purported class actions predicated on the theory that cigarette
manufacturers should be liable for damages alleged to have been
caused by cigarette smoking or by exposure to secondary smoke from
cigarettes. The cases have generally fallen into the following
categories: (i) smoking and health cases alleging personal injury
brought on behalf of individual plaintiffs (“Individual Actions”);
(ii) lawsuits by individuals requesting the benefit of the
Engle
ruling (“Engle
progeny cases”); (iii) smoking and health cases primarily alleging
personal injury or seeking court-supervised programs for ongoing
medical monitoring, as well as cases alleging that use of the terms
“lights” and/or “ultra lights” constitutes a deceptive and unfair
trade practice, common law fraud or violation of federal law,
purporting to be brought on behalf of a class of individual
plaintiffs (“Class Actions”); and (iv) health care cost recovery
actions brought by various foreign and domestic governmental
plaintiffs and non-governmental plaintiffs seeking reimbursement
for health care expenditures allegedly caused by cigarette smoking
and/or disgorgement of profits (“Health Care Cost Recovery
Actions”). The future financial impact of the risks and expenses of
litigation are not quantifiable. For the three months ended
March 31, 2022 and 2021, Liggett incurred tobacco product
liability legal expenses and costs totaling $1,645 and $1,525
respectively. Legal defense costs are expensed as
incurred.
Litigation is subject to uncertainty and it is possible that there
could be adverse developments in pending cases. With the
commencement of new cases, the defense costs and the risks relating
to the unpredictability of litigation increase. Management reviews
on a quarterly basis with counsel all pending litigation and
evaluates the probability of a loss being incurred and whether an
estimate can be made of the possible loss or range of loss
that could result from an unfavorable outcome. An unfavorable
outcome or settlement of pending tobacco-related litigation could
encourage the commencement of additional litigation. Damages
awarded in tobacco-related litigation can be
significant.
Bonds.
Although Liggett has been able to obtain required bonds or relief
from bonding requirements in order to prevent plaintiffs from
seeking to collect judgments while adverse verdicts are on appeal,
there remains a risk that such relief may not be obtainable in all
cases. This risk has been reduced given that a majority of states
now limit the dollar amount of bonds or require no bond at all. As
of March 31, 2022, Liggett had no outstanding
bonds.
In June 2009, Florida amended its existing bond cap statute by
adding a $200,000 bond cap that applies to all Florida tobacco
litigation in the aggregate and establishes individual bond caps in
amounts that vary depending on the number of judgments in effect at
a given time. The maximum amount of any such bond for an appeal in
the Florida state courts will be no greater than $5,000. In several
cases, plaintiffs challenged the constitutionality of the bond cap
statute, but to date the courts have upheld the constitutionality
of the statute. It is possible that the Company’s consolidated
financial position, results of operations, and cash flows could be
materially adversely affected by an unfavorable outcome of such
challenges.
Accounting Policy.
The Company and its subsidiaries record provisions in their
consolidated financial statements for pending litigation when they
determine that an unfavorable outcome is probable and the amount of
loss can be reasonably estimated. At the present time, while it is
reasonably possible that an unfavorable outcome in a case may
occur, except as discussed in this Note 9: (i) management has
concluded that it is not probable that a loss has been incurred in
any of the pending tobacco-related cases; or (ii) management is
unable to reasonably estimate the possible loss or range of loss
that could result from an unfavorable outcome of any of the pending
tobacco-related cases and, therefore, management has not provided
any amounts in the condensed consolidated financial statements for
unfavorable outcomes, if any.
Although Liggett has generally been successful in managing the
litigation filed against it, litigation is subject to uncertainty
and significant challenges remain, including with respect to the
remaining
Engle
progeny cases. There can be no assurances that Liggett’s past
litigation experience will be representative of future results.
Judgments have been entered against Liggett in the past, in
Individual Actions and
Engle
progeny cases, and several of those judgments were affirmed on
appeal and satisfied by Liggett. It is possible that the
consolidated financial position, results of operations and cash
flows of the Company could be materially adversely affected by an
unfavorable outcome or settlement of any of the remaining
smoking-related litigation. Liggett believes, and has been so
advised by counsel, that it has valid defenses to the litigation
pending against it, as well as valid bases for appeal of adverse
verdicts. All such cases are and will continue to be vigorously
defended. Liggett has entered into settlement discussions in
individual cases or groups of cases where Liggett has determined it
was in its best interest to do so, and it may continue to do so in
the future. As cases proceed through the appellate process, the
Company will consider accruals on a case-by-case basis if an
unfavorable outcome becomes probable and the amount can be
reasonably estimated.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Individual Actions
As of March 31, 2022, there were 61
Individual Actions pending against Liggett, where one or more
individual plaintiffs allege injury resulting from cigarette
smoking, addiction to cigarette smoking or exposure to secondary
smoke and seek compensatory and, in some cases, punitive damages.
These cases do not include the remaining
Engle
progeny cases. The following table lists the number of Individual
Actions by state:
|
|
|
|
|
|
|
|
|
State |
|
Number
of Cases |
Florida |
|
30 |
Illinois |
|
14 |
Nevada |
|
5 |
New Mexico |
|
4 |
Hawaii |
|
4 |
Louisiana |
|
2 |
Massachusetts |
|
1 |
South Carolina |
|
1 |
The plaintiffs’ allegations of liability in cases in which
individuals seek recovery for injuries allegedly caused by
cigarette smoking are based on various theories of recovery,
including negligence, gross negligence, breach of special duty,
strict liability, fraud, concealment, misrepresentation, design
defect, failure to warn, breach of express and implied warranties,
conspiracy, aiding and abetting, concert of action, unjust
enrichment, common law public nuisance, property damage, invasion
of privacy, mental anguish, emotional distress, disability, shock,
indemnity, violations of deceptive trade practice laws, the federal
Racketeer Influenced and Corrupt Organizations Act (“RICO”), state
RICO statutes and antitrust statutes. In many of these cases, in
addition to compensatory damages, plaintiffs also seek other forms
of relief including treble/multiple damages, medical monitoring,
disgorgement of profits and punitive damages. Although alleged
damages often are not determinable from a complaint, and the law
governing the pleading and calculation of damages varies from state
to state and jurisdiction to jurisdiction, compensatory and
punitive damages have been specifically pleaded in a number of
cases, sometimes in amounts ranging into the hundreds of millions
and even billions of dollars.
Defenses raised in Individual Actions include lack of proximate
cause, assumption of the risk, comparative fault and/or
contributory negligence, lack of design defect, statute of
limitations, statute of repose, equitable defenses such as “unclean
hands” and lack of benefit, failure to state a claim and federal
preemption.
Engle Progeny Cases
In May 1994, the
Engle
case was filed as a class action against Liggett and others in
Miami-Dade County, Florida. The class consisted of all Florida
residents who, by November 21, 1996, “have suffered, presently
suffer or have died from diseases and medical conditions caused by
their addiction to cigarette smoking.” A trial was held and the
jury returned a verdict adverse to the defendants (approximately
$145,000,000 in punitive damages, including $790,000 against
Liggett). Following an appeal to the Third District Court of
Appeal, the Florida Supreme Court in July 2006 decertified the
class on a prospective basis and affirmed the appellate court’s
reversal of the punitive damages award. Former class members had
until January 2008 to file individual lawsuits. As a result,
Liggett and the Company, and other cigarette manufacturers, were
sued in thousands of
Engle
progeny cases in both federal and state courts in
Florida.
Cautionary Statement About Engle Progeny Cases.
Since 2009, judgments have been entered against Liggett and other
cigarette manufacturers in
Engle
progeny cases. A number of the judgments were affirmed on appeal
and satisfied by the defendants. Many were overturned on appeal. As
of March 31, 2022, 25
Engle
progeny cases, where Liggett was a defendant at trial, resulted in
verdicts.
There have been 16 verdicts returned in favor of the plaintiffs and
nine in favor of Liggett. In five of the cases, punitive damages
were awarded against Liggett. Several of the adverse verdicts were
overturned on appeal and new trials were ordered. In certain cases,
the judgments were entered jointly and severally with other
defendants and Liggett faces the risk that one or more
co-defendants decline or otherwise fail to participate in the
bonding required for an appeal or to pay their proportionate or
jury-allocated share of a judgment. As a result, under certain
circumstances, Liggett may have to pay more than its proportionate
share of any bonding or judgment related amounts. Except as
discussed in this Note 9, management is unable to
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
estimate the possible loss or range of loss from the
remaining
Engle
progeny cases as there are currently multiple defendants in each
case, except as discussed herein and, in most cases, discovery has
not occurred or is limited. As a result, the Company lacks
information about whether plaintiffs are in fact
Engle
class members, the relevant smoking history, the nature of the
alleged injury and the availability of various defenses, among
other things. Further, plaintiffs typically do not specify the
amount of their demand for damages.
Engle Progeny Settlements.
In October 2013, the Company and Liggett entered into a settlement
with approximately 4,900
Engle
progeny plaintiffs and their counsel. Pursuant to the terms of the
settlement, Liggett agreed to pay a total of approximately
$110,000, with $61,600 paid in an initial lump sum and the balance
to be paid in installments over 14 years starting in February 2015.
The Company’s future payments will be approximately $3,600 per
annum through 2028, including an annual cost of living increase
that began in 2021. In exchange, the claims of these plaintiffs
were dismissed with prejudice against the Company and
Liggett.
Liggett subsequently entered into two separate settlement
agreements with a total of 152
Engle
progeny plaintiffs where Liggett paid a total of $23,150. On an
individual basis, Liggett settled an additional 207
Engle
progeny cases for approximately $8,200 in the aggregate. Three of
those settlements occurred in the first quarter of
2022.
Notwithstanding the comprehensive nature of the
Engle
progeny settlements, 25 plaintiffs’ claims remain pending in state
court. Therefore, the Company and Liggett may still be subject to
periodic adverse judgments which could have a material adverse
effect on the Company’s consolidated financial position, results of
operations and cash flows.
Judgments Paid in Engle Progeny Cases.
As of March 31, 2022, Liggett paid in the aggregate $40,111,
including interest and attorneys’ fees, to satisfy the judgments in
the following
Engle
progeny cases:
Lukacs,
Campbell,
Douglas,
Clay,
Tullo, Ward, Rizzuto, Lambert,
Buchanan,
and
Santoro.
Liggett Only Cases
There are currently five cases where Liggett is the sole
defendant:
Cowart
and
Baluja
are Individual Actions and
Tumin,
Forbing,
and
Alvarez
are
Engle
progeny cases. It is possible that cases where Liggett is the only
defendant could increase as a result of the remaining
Engle
progeny cases and newly filed Individual Actions.
Upcoming Trials
As of March 31, 2022, there were eight Individual Actions
(Camacho,
Geist, Harcourt, Johnson, Lane, Mendez, Rowan, and
Sweet)
scheduled for trial through March 31, 2023, where Liggett is a
named defendant. Trial dates are subject to change and additional
cases could be set for trial during this time.
Maryland Cases
Liggett was a defendant in 16 multi-defendant personal injury cases
in Maryland alleging claims arising from asbestos and tobacco
exposure (“synergy cases”). In June 2017, after the Court of
Appeals (Maryland’s highest court) ruled that joinder of tobacco
and asbestos cases may be possible in certain circumstances and
then remanded the case, the trial court dismissed all synergy cases
against the tobacco company defendants, including Liggett, without
prejudice. At some point, Plaintiffs may seek appellate review or
file new cases against the tobacco companies.
Class Actions
As of March 31, 2022, two actions were pending for which
either a class had been certified or plaintiffs were seeking class
certification where Liggett is a named defendant. Other cigarette
manufacturers are also named in these two cases.
In November 1997, in
Young v. American Tobacco Co.,
a purported class action was brought on behalf of plaintiff and all
similarly situated residents in Louisiana who, though not
themselves cigarette smokers, allege they were exposed to and
suffered injury from secondhand smoke from cigarettes. The
plaintiffs seek an unspecified amount of compensatory and punitive
damages. The case has been stayed since March 2016 pending
completion of the smoking cessation program ordered by the court
in
Scott v. The American Tobacco Co.
In February 1998, in
Parsons v. AC & S Inc.,
a purported class action was brought on behalf of plaintiff and all
West Virginia residents who allegedly have claims arising from
their exposure to cigarette smoke and asbestos fibers and seeks
compensatory and punitive damages. The case has been stayed since
December 2000 as a result of bankruptcy petitions filed by three
co-defendants.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Plaintiffs’ allegations of liability in class action cases are
based on various theories of recovery, including negligence, gross
negligence, strict liability, fraud, misrepresentation, design
defect, failure to warn, nuisance, breach of express and implied
warranties, breach of special duty, conspiracy, concert of action,
violation of deceptive trade practice laws and consumer protection
statutes and claims under the federal and state anti-racketeering
statutes. Plaintiffs in the class actions seek various forms of
relief, including compensatory and punitive damages,
treble/multiple damages and other statutory damages and penalties,
creation of medical monitoring and smoking cessation funds,
disgorgement of profits, and injunctive and equitable
relief.
Defenses raised in these cases include, among others, lack of
proximate cause, individual issues predominate, assumption of the
risk, comparative fault and/or contributory negligence, statute of
limitations and federal preemption.
Health Care Cost Recovery Actions
As of March 31, 2022, one Health Care Cost Recovery Action was
pending against Liggett where the plaintiff seeks to recover
damages from Liggett and other cigarette manufacturers based on
various theories of recovery as a result of alleged sales of
tobacco products to minors. The case is dormant.
The claims asserted in health care cost recovery actions vary, but
can include the equitable claim of indemnity, common law claims of
negligence, strict liability, breach of express and implied
warranty, breach of special duty, fraud, negligent
misrepresentation, conspiracy, public nuisance, claims under state
and federal statutes governing consumer fraud, antitrust, deceptive
trade practices and false advertising, and claims under RICO.
Although no specific damage amounts are typically pleaded, it is
possible that requested damages might be in the billions of
dollars. In these cases, plaintiffs have asserted equitable claims
that the tobacco industry was “unjustly enriched” by their payment
of health care costs allegedly attributable to smoking and seek
reimbursement of those costs. Relief sought by some, but not all,
plaintiffs include punitive damages, multiple damages and other
statutory damages and penalties, injunctions prohibiting alleged
marketing and sales to minors, disclosure of research, disgorgement
of profits, funding of anti-smoking programs, additional disclosure
of nicotine yields, and payment of attorney and expert witness
fees.
Department of Justice Lawsuit
In September 1999, the United States government commenced
litigation against Liggett and other cigarette manufacturers in the
United States District Court for the District of Columbia. The
action sought to recover, among other things, an unspecified amount
of health care costs paid and to be paid by the federal government
for smoking-related illnesses allegedly caused by the fraudulent
and tortious conduct of defendants. In August 2006, the trial court
entered a Final Judgment against each of the cigarette
manufacturing defendants, except Liggett. The judgment was affirmed
on appeal. As a result, the cigarette manufacturing defendants,
other than Liggett, are now subject to the trial court’s Final
Judgment which ordered, among other things, the issuance of
“corrective statements” in various media regarding the adverse
health effects of smoking, the addictiveness of smoking and
nicotine, the lack of any significant health benefit from smoking
“low tar” or “lights” cigarettes, defendants’ manipulation of
cigarette design to ensure optimum nicotine delivery and the
adverse health effects of exposure to environmental tobacco
smoke.
MSA and Other State Settlement Agreements
In March 1996, March 1997 and March 1998, Liggett entered into
settlements of smoking-related litigation with 45 states and
territories. The settlements released Liggett from all
smoking-related claims made by those states and territories,
including claims for health care cost reimbursement and claims
concerning sales of cigarettes to minors.
In November 1998, Philip Morris, R.J. Reynolds and two other
companies (the “Original Participating Manufacturers” or “OPMs”)
and Liggett and Vector Tobacco (together with any other tobacco
product manufacturer that becomes a signatory, the “Subsequent
Participating Manufacturers” or “SPMs”) (the OPMs and SPMs are
hereinafter referred to jointly as “PMs”) entered into the Master
Settlement Agreement (the “MSA”) with 46 states, the District of
Columbia, Puerto Rico, Guam, the United States Virgin Islands,
American Samoa and the Northern Mariana Islands (collectively, the
“Settling States”) to settle the asserted and unasserted health
care cost recovery and certain other claims of the Settling States.
The MSA received final judicial approval in each Settling
State.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
As a result of the MSA, the Settling States released Liggett and
Vector Tobacco from:
•all
claims of the Settling States and their respective political
subdivisions and other recipients of state health care funds,
relating to: (i) past conduct arising out of the use, sale,
distribution, manufacture, development, advertising and marketing
of tobacco products; (ii) the health effects of, the exposure to,
or research, statements or warnings about, tobacco products;
and
•all
monetary claims of the Settling States and their respective
subdivisions and other recipients of state health care funds
relating to future conduct arising out of the use of, or exposure
to, tobacco products that have been manufactured in the ordinary
course of business.
The MSA restricts tobacco product advertising and marketing within
the Settling States and otherwise restricts the activities of PMs.
Among other things, the MSA prohibits the targeting of youth in the
advertising, promotion or marketing of tobacco products; bans the
use of cartoon characters in all tobacco advertising and promotion;
limits each PM to one tobacco brand name sponsorship during any
12-month period; bans all outdoor advertising, with certain limited
exceptions; prohibits payments for tobacco product placement in
various media; bans gift offers based on the purchase of tobacco
products without sufficient proof that the intended recipient is an
adult; prohibits PMs from licensing third parties to advertise
tobacco brand names in any manner prohibited under the MSA; and
prohibits PMs from using as a tobacco product brand name any
nationally recognized non-tobacco brand or trade name or the names
of sports teams, entertainment groups or individual
celebrities.
The MSA also requires PMs to affirm corporate principles to comply
with the MSA and to reduce underage use of tobacco products and
imposes restrictions on lobbying activities conducted on behalf of
PMs. In addition, the MSA provides for the appointment of an
independent auditor to calculate and determine the amounts of
payments owed pursuant to the MSA.
Under the payment provisions of the MSA, PMs are required to make
annual payments of $9,000,000 (subject to applicable adjustments,
offsets and reductions including a “Non-Participating Manufacturers
Adjustment” or “NPM Adjustment”). These annual payments are
allocated based on unit volume of domestic cigarette shipments. The
payment obligations under the MSA are the several, and not joint,
obligations of each PM and are not the responsibility of any parent
or affiliate of a PM.
Liggett has no payment obligations under the MSA except to the
extent its market share exceeds a market share exemption of
approximately 1.65% of total cigarettes sold in the United States.
Vector Tobacco has no payment obligations under the MSA except to
the extent its market share exceeds a market share exemption of
approximately 0.28% of total cigarettes sold in the United States.
Liggett and Vector Tobacco’s domestic shipments accounted for
approximately 4.1% of the total cigarettes sold in the United
States in 2021. If Liggett’s or Vector Tobacco’s market share
exceeds their respective market share exemption in a given year,
then on April 15 of the following year, Liggett and/or Vector
Tobacco, as the case may be, must pay on each excess unit an amount
equal (on a per-unit basis) to that due from the OPMs for that
year. On December 30, 2021, Liggett and Vector Tobacco pre-paid
$169,500 of their approximate $179,000 2021 MSA obligation, the
balance of which was paid in April 2022, subject to applicable
disputes or adjustments.
Certain MSA Disputes
NPM Adjustment. Liggett
and Vector Tobacco contend that they are entitled to an NPM
Adjustment for each year from 2003 - 2021. The NPM Adjustment is a
potential adjustment to annual MSA payments, available when PMs
suffer a market share loss to NPMs for a particular year and an
economic consulting firm selected pursuant to the MSA determines
(or the parties agree) that the MSA was a “significant factor
contributing to” that loss. A Settling State that has “diligently
enforced” its qualifying escrow statute in the year in question may
be able to avoid its allocable share of the NPM Adjustment. For
2003 - 2021, Liggett and Vector Tobacco, as applicable,
disputed that they owed the Settling States the NPM Adjustments as
calculated by the independent auditor. As permitted by the MSA,
Liggett and Vector Tobacco either paid subject to dispute, withheld
payment, or paid into a disputed payment account, the amounts
associated with these NPM Adjustments.
In June 2010, after the PMs prevailed in 48
of 49 motions to compel arbitration, the parties commenced the
arbitration for the 2003 NPM Adjustment. That arbitration concluded
in September 2013. It was followed by various challenges filed in
state courts by states that did not prevail in the arbitration.
Those challenges resulted in reductions, but not elimination of,
the amounts awarded. Since then, the PMs have settled the NPM
Adjustment dispute with 39 states representing approximately 80% of
the MSA allocable share.
The 2004 NPM Adjustment arbitration commenced in 2016, with the
arbitration panel issuing interim decisions on most individual
states in September 2021, finding two of them liable for the NPM
Adjustment; the final individual state hearing was held in February
2022; and a second phase addressing the effect of the settlements
on recovery of the NPM Adjustment to start
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
thereafter. The parties have selected an arbitration panel to
address the NPM Adjustments for 2005-2007, and are engaged in
discovery, with a common hearing set for July 2022 and individual
state hearings likely to start in the third quarter of
2022.
As a result of the settlements described above, Liggett and Vector
Tobacco reduced cost of sales for three months ended March 31,
2022 and 2021 by $4,781 and $1,675 respectively. Liggett and Vector
Tobacco may be entitled to further adjustments. As of
March 31, 2022, Liggett and Vector Tobacco had accrued
approximately $11,100 related to the disputed amounts withheld from
the non-settling states for 2004 - 2010, which may be subject to
payment, with interest, if Liggett and Vector Tobacco lose the
disputes for those years. As of March 31, 2022, there remains
approximately $49,800 in the disputed payments account relating to
Liggett and Vector Tobacco’s 2011 - 2020 NPM Adjustment disputes
with the non-settling states. If Liggett and Vector Tobacco lose
the disputes for all or any of those years, pursuant to the MSA, no
interest would be due on the amounts paid into the disputed payment
account.
Other State Settlements. The
MSA replaced Liggett’s prior settlements with all states and
territories except for Florida, Mississippi, Texas and Minnesota.
Each of these four states, prior to the effective date of the MSA,
negotiated and executed settlement agreements with each of the
other major tobacco companies, separate from those settlements
reached previously with Liggett. Except as described below,
Liggett’s agreements with these states remain in full force and
effect. These states’ settlement agreements with Liggett contained
most favored nation provisions which could reduce Liggett’s payment
obligations based on subsequent settlements or resolutions by those
states with certain other tobacco companies. Beginning in 1999,
Liggett determined that, based on settlements or resolutions with
United States Tobacco Company, Liggett’s payment obligations to
those four states were eliminated. With respect to all non-economic
obligations under the previous settlements, Liggett believes it is
entitled to the most favorable provisions as between the MSA and
each state’s respective settlement with the other major tobacco
companies. Therefore, Liggett’s non-economic obligations to all
states and territories are now defined by the MSA.
In 2003, as a result of a dispute with Minnesota regarding its
settlement agreement, Liggett agreed to pay $100 a year in any year
cigarettes manufactured by Liggett are sold in that state. Further,
the Attorneys General for Florida, Mississippi and Texas advised
Liggett that they believed Liggett had failed to make payments
under the respective settlement agreements with those states. In
2010, Liggett settled with Florida and agreed to pay $1,200 and to
make further annual payments of $250 for a period of 21 years,
starting in March 2011, with the payments from March
2022 forward being subject to an inflation
adjustment.
Mississippi Litigation.
In January 2016, the Attorney General for Mississippi filed a
motion in Chancery Court in Jackson County, Mississippi to enforce
the March 1996 settlement agreement among Liggett, Mississippi and
other states (the “1996 Agreement”) alleging that Liggett owes
Mississippi at least $27,000 in compensatory damages and interest.
In April 2017, the Chancery Court ruled, over Liggett’s objections,
that the 1996 Agreement should be enforced as Mississippi claims
and referred the matter first to arbitration and then to a Special
Master for further proceedings to determine the amount of damages,
if any, to be awarded. In April 2021, following confirmation
of the final arbitration award, the parties stipulated that the
unpaid principal (exclusive of interest) purportedly due from
Liggett to Mississippi pursuant to the 1996 Agreement was
approximately $16,700, subject to Liggett’s right to litigate
and/or appeal the enforceability of the 1996 Agreement (and all
issues other than the calculation of the principal amount allegedly
due).
In September 2019, the Special Master held a hearing regarding
Mississippi’s claim for pre- and post-judgment interest. In August
2021, the Special Master issued a final report with proposed
findings and recommendations that pre-judgment interest, in the
amount of approximately $18,800, is due from Liggett from April
2005 - August 3, 2021. In April 2022, the Mississippi Chancery
Court affirmed the Special Master’s findings. Additional interest
amounts will accrue if the judgment is not overturned on appeal.
Liggett continues to assert that the April 2017 Chancery Court
order is in error because the most favored nations provision in the
1996 Agreement eliminated all of Liggett’s payment obligations to
Mississippi, and has reserved all rights to appeal this and other
issues at the conclusion of the case. In the event Liggett appeals
an adverse judgment, the posting of a bond will likely be
required.
Liggett may be required to make additional payments to Mississippi
and/or Texas which could have a material adverse effect on the
Company’s consolidated financial position, results of operations
and cash flows.
Cautionary Statement
Management is not able to reasonably predict the outcome of the
litigation pending or threatened against Liggett or the Company.
Litigation is subject to many uncertainties. Liggett has been found
liable in multiple
Engle
progeny cases and Individual Actions, several of which were
affirmed on appeal and satisfied by Liggett. It is possible that
other cases could be decided unfavorably against Liggett and that
Liggett will be unsuccessful on appeal. Liggett may attempt to
settle particular cases if it believes it is in its best interest
to do so.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
Management cannot predict the cash requirements related to any
future defense costs, settlements or judgments, including cash
required to bond any appeals, and there is a risk that Liggett may
not be able to meet those requirements. An unfavorable outcome of a
pending smoking-related case could encourage the commencement of
additional litigation. Except as discussed in this Note 9,
management is unable to estimate the loss or range of loss that
could result from an unfavorable outcome of the cases pending
against Liggett or the costs of defending such cases and as a
result has not provided any amounts in its condensed consolidated
financial statements for unfavorable outcomes.
The tobacco industry is subject to a wide range of laws and
regulations regarding the marketing, sale, taxation and use of
tobacco products imposed by local, state and federal governments.
There have been a number of restrictive regulatory actions, adverse
legislative and political decisions and other unfavorable
developments concerning cigarette smoking and the tobacco industry.
These developments may negatively affect the perception of
potential triers of fact with respect to the tobacco industry,
possibly to the detriment of certain pending litigation, and may
prompt the commencement of additional litigation or
legislation.
It is possible that the Company’s consolidated financial position,
results of operations and cash flows could be materially adversely
affected by an unfavorable outcome in any of the smoking-related
litigation.
The activity in the Company’s accruals for the MSA and tobacco
litigation for the three months ended March 31, 2022 was as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Liabilities |
|
Non-Current Liabilities |
|
Payments due under Master Settlement Agreement |
|
Litigation Accruals |
|
Total |
|
Payments due under Master Settlement Agreement |
|
Litigation Accruals |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of January 1, 2022 |
$ |
11,886 |
|
|
$ |
3,918 |
|
|
$ |
15,804 |
|
|
$ |
13,224 |
|
|
$ |
17,680 |
|
|
$ |
30,904 |
|
Expenses
|
56,199 |
|
|
72 |
|
|
56,271 |
|
|
— |
|
|
— |
|
|
— |
|
NPM Settlement adjustment
|
(15) |
|
|
— |
|
|
(15) |
|
|
(2,108) |
|
|
— |
|
|
(2,108) |
|
Change in MSA obligations capitalized as inventory
|
521 |
|
|
— |
|
|
521 |
|
|
— |
|
|
— |
|
|
— |
|
Payments
|
— |
|
|
(3,917) |
|
|
(3,917) |
|
|
— |
|
|
— |
|
|
— |
|
Reclassification to/(from) non-current liabilities
|
— |
|
|
3,566 |
|
|
3,566 |
|
|
— |
|
|
(3,566) |
|
|
(3,566) |
|
Interest on withholding
|
— |
|
|
124 |
|
|
124 |
|
|
— |
|
|
472 |
|
|
472 |
|
Balance as of March 31, 2022 |
$ |
68,591 |
|
|
$ |
3,763 |
|
|
$ |
72,354 |
|
|
$ |
11,116 |
|
|
$ |
14,586 |
|
|
$ |
25,702 |
|
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
The activity in the Company’s accruals for the MSA and tobacco
litigation for the three months ended March 31, 2021 was as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Liabilities |
|
Non-Current Liabilities |
|
Payments due under Master Settlement Agreement |
|
Litigation Accruals |
|
Total |
|
Payments due under Master Settlement Agreement |
|
Litigation Accruals |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of January 1, 2021 |
$ |
38,767 |
|
|
$ |
3,967 |
|
|
$ |
42,734 |
|
|
$ |
17,933 |
|
|
$ |
19,268 |
|
|
$ |
37,201 |
|
Expenses
|
34,121 |
|
|
5 |
|
|
34,126 |
|
|
— |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in MSA obligations capitalized as inventory
|
148 |
|
|
— |
|
|
148 |
|
|
— |
|
|
— |
|
|
— |
|
Payments
|
— |
|
|
(4,065) |
|
|
(4,065) |
|
|
— |
|
|
— |
|
|
— |
|
Reclassification to/(from) non-current liabilities
|
— |
|
|
3,351 |
|
|
3,351 |
|
|
— |
|
|
(3,351) |
|
|
(3,351) |
|
Interest on withholding
|
— |
|
|
197 |
|
|
197 |
|
|
— |
|
|
418 |
|
|
418 |
|
Balance as of March 31, 2021 |
$ |
73,036 |
|
|
$ |
3,455 |
|
|
$ |
76,491 |
|
|
$ |
17,933 |
|
|
$ |
16,335 |
|
|
$ |
34,268 |
|
Other Matters:
Liggett’s and Vector Tobacco’s management are unaware of any
material environmental conditions affecting their existing
facilities. Liggett’s and Vector Tobacco’s management believe that
current operations are conducted in material compliance with all
environmental laws and regulations and other laws and regulations
governing cigarette manufacturers. Compliance with federal, state
and local provisions regulating the discharge of materials into the
environment, or otherwise relating to the protection of the
environment, has not had a material impact on the capital
expenditures, results of operations or competitive position of
Liggett or Vector Tobacco.
Liggett and the Company have received three separate demands for
indemnification from Altria Client Services, on behalf of Philip
Morris, relating to lawsuits alleging smokers’ use of L&M
cigarettes. The indemnification demands are purportedly issued in
connection with Eve Holdings’ 1999 sale of certain trademarks to
Philip Morris.
Management is of the opinion that the liabilities, if any,
resulting from other proceedings, lawsuits and claims pending
against the Company and its consolidated subsidiaries, unrelated to
tobacco product liability, should not materially affect the
Company’s consolidated financial position, results of operations or
cash flows.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
10. INCOME
TAXES
The Company’s effective income tax rate is based on expected
income, statutory rates, valuation allowances against deferred tax
assets, and any tax planning opportunities available to the
Company. For interim financial reporting, the Company estimates the
annual effective income tax rate based on full year projections and
applies the annual effective income tax rate against year-to-date
pretax income to record income tax expense, adjusted for discrete
items, if any. The Company refines annual estimates as new
information becomes available. The Company’s tax rate does not bear
a relationship to statutory tax rates due to permanent differences,
which are primarily related to nondeductible compensation and state
taxes.
The Company’s income tax expense consisted of the
following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
|
|
2022 |
|
2021 |
Income before provision for income taxes |
|
|
|
|
$ |
44,764 |
|
|
$ |
30,764 |
|
Income tax expense using estimated annual effective income tax
rate
|
|
|
|
|
12,222 |
|
|
9,214 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense |
|
|
|
|
$ |
12,222 |
|
|
$ |
9,214 |
|
There are no discrete items for the three months ended
March 31, 2022 or the three months ended March 31,
2021.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
11. INVESTMENTS
AND FAIR VALUE MEASUREMENTS
The Company’s financial assets and liabilities subject to fair
value measurements were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements as of March 31, 2022 |
|
|
Total |
|
Quoted Prices in Active Markets for Identical Assets
(Level 1) |
|
Significant
Other Observable Inputs
(Level 2) |
|
Significant
Unobservable Inputs
(Level 3) |
Assets: |
|
|
|
|
|
|
|
|
Money market funds
(1)
|
|
$ |
153,948 |
|
|
$ |
153,948 |
|
|
$ |
— |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
Commercial paper
(1)
|
|
43,002 |
|
|
— |
|
|
43,002 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
Certificates of deposit
(2)
|
|
110 |
|
|
— |
|
|
110 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment securities at fair value |
|
|
|
|
|
|
|
|
Equity securities at fair value |
|
|
|
|
|
|
|
|
Marketable equity securities
|
|
18,962 |
|
|
18,962 |
|
|
— |
|
|
— |
|
Mutual funds invested in debt
securities
|
|
22,538 |
|
|
22,538 |
|
|
— |
|
|
— |
|
Total equity
securities at fair value
|
|
41,500 |
|
|
41,500 |
|
|
— |
|
|
— |
|
Debt securities available for
sale |
|
|
|
|
|
|
|
|
U.S. government securities
|
|
5,585 |
|
|
— |
|
|
5,585 |
|
|
— |
|
Corporate securities
|
|
55,324 |
|
|
— |
|
|
55,324 |
|
|
— |
|
U.S. government and federal agency
|
|
19,173 |
|
|
— |
|
|
19,173 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial paper
|
|
10,540 |
|
|
— |
|
|
10,540 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
Foreign fixed-income securities
|
|
1,216 |
|
|
— |
|
|
1,216 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
Total debt securities available for sale
|
|
91,838 |
|
|
— |
|
|
91,838 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
Total investment securities at fair value
|
|
133,338 |
|
|
41,500 |
|
|
91,838 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
Long-term investments |
|
|
|
|
|
|
|
|
Long-term investment securities at fair value
(3)
|
|
31,057 |
|
|
— |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
361,455 |
|
|
$ |
195,448 |
|
|
$ |
134,950 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
Fair value of contingent liability |
|
$ |
965 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
965 |
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
965 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
965 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Amounts included in Cash and cash
equivalents on the condensed consolidated balance
sheets.
(2) Amounts included in current restricted
assets and non-current restricted assets on the condensed
consolidated balance sheets.
(3) In accordance with Subtopic 820-10,
investments that are measured at fair value using the NAV practical
expedient are not classified in the fair value
hierarchy.
VECTOR GROUP LTD.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS –
(Continued)
(Dollars in Thousands, Except Per Share Amounts)
Unaudited
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements as of December 31, 2021 |
|
|
Total |
|
Quoted Prices in Active Markets for Identical Assets
(Level 1) |
|
Significant
Other Observable Inputs
(Level 2) |
|
Significant
Unobservable Inputs
(Level 3) |
Assets: |
|
|
|
|
|
|
|
|
Money market funds
(1)
|
|
$ |
130,583 |
|
|
$ |
130,583 |
|
|
$ |
— |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
Commercial paper
(1)
|
|
24,426 |
|
|
|
|
24,426 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
Certificates of deposit
(2)
|
|
110 |
|
|
|
|
110 |
|
|
— |
|
|
|
|
|
|
|
|
|
|